These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
|
|
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
|
|
|
|
4.625% Subordinated Notes due 2061 of Carlyle
Finance L.L.C.
|
|
|
|
|
|
☒
|
|
Accelerated filer
|
|
☐
|
|
Non-accelerated filer
|
|
☐
|
|
Smaller reporting company
|
|
|
|
Emerging growth company
|
|
|
||||
|
|
|
Page
|
|
Item 1.
|
||
|
Unaudited Condensed Consolidated Financial Statements –
September 30, 2025
and
2024
:
|
||
|
Item 2.
|
||
|
Item 3.
|
||
|
Item 4.
|
||
|
Item 1.
|
||
|
Item 1A.
|
||
|
Item 2.
|
||
|
Item 3.
|
||
|
Item 4.
|
||
|
Item 5.
|
||
|
Item 6.
|
||
|
September 30,
2025
|
December 31,
2024
|
||
|
|
(Unaudited)
|
||
|
Assets
|
|||
|
Cash and cash equivalents
|
$
|
$
|
|
|
Cash and cash equivalents held at Consolidated Funds
|
|
|
|
|
Investments, including accrued performance allocations of
$
September 30, 2025
and
December 31, 2024
, respectively
|
|
|
|
|
Investments of Consolidated Funds
|
|
|
|
|
Due from affiliates and other receivables, net
|
|
|
|
|
Due from affiliates and other receivables of Consolidated Funds, net
|
|
|
|
|
Fixed assets, net
|
|
|
|
|
Lease right-of-use assets, net
|
|
|
|
|
Deposits and other
|
|
|
|
|
Intangible assets, net
|
|
|
|
|
Deferred tax assets
|
|
|
|
|
Total assets
|
$
|
$
|
|
|
Liabilities and equity
|
|||
|
Debt obligations
|
$
|
$
|
|
|
Loans payable of Consolidated Funds
|
|
|
|
|
Accounts payable, accrued expenses and other liabilities
|
|
|
|
|
Accrued compensation and benefits
|
|
|
|
|
Due to affiliates
|
|
|
|
|
Deferred revenue
|
|
|
|
|
Deferred tax liabilities
|
|
|
|
|
Other liabilities of Consolidated Funds
|
|
|
|
|
Lease liabilities
|
|
|
|
|
Accrued giveback obligations
|
|
|
|
|
Total liabilities
|
|
|
|
|
Commitments and contingencies
|
|
|
|
|
Common stock,
$
2024
, respectively)
|
|
|
|
|
Additional paid-in-capital
|
|
|
|
|
Retained earnings
|
|
|
|
|
Accumulated other comprehensive loss
|
(
|
(
|
|
|
Non-controlling interests in consolidated entities
|
|
|
|
|
Total equity
|
|
|
|
|
Total liabilities and equity
|
$
|
$
|
|
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||
|
|
2025
|
2024
|
2025
|
2024
|
|||
|
Revenues
|
|||||||
|
Fund management fees
|
$
|
$
|
$
|
$
|
|||
|
Incentive fees
|
|
|
|
|
|||
|
Investment income (loss)
|
|||||||
|
Performance allocations
|
(
|
|
|
|
|||
|
Principal investment income
|
|
|
|
|
|||
|
Total investment income (loss)
|
(
|
|
|
|
|||
|
Interest and other income
|
|
|
|
|
|||
|
Interest and other income of Consolidated Funds
|
|
|
|
|
|||
|
Total revenues
|
|
|
|
|
|||
|
Expenses
|
|||||||
|
Compensation and benefits
|
|||||||
|
Cash-based compensation and benefits
|
|
|
|
|
|||
|
Equity-based compensation
|
|
|
|
|
|||
|
Performance allocations and incentive fee related compensation
|
(
|
|
|
|
|||
|
Total compensation and benefits
|
(
|
|
|
|
|||
|
General, administrative and other expenses
|
|
|
|
|
|||
|
Interest
|
|
|
|
|
|||
|
Interest and other expenses of Consolidated Funds
|
|
|
|
|
|||
|
Other non-operating income
|
|
(
|
(
|
(
|
|||
|
Total expenses
|
|
|
|
|
|||
|
Other income (loss)
|
|||||||
|
Net investment income (loss) of Consolidated Funds
|
|
|
|
(
|
|||
|
Income before provision (benefit) for income taxes
|
|
|
|
|
|||
|
Provision (benefit) for income taxes
|
(
|
|
|
|
|||
|
Net income
|
|
|
|
|
|||
|
Net income attributable to non-controlling interests in consolidated entities
|
|
|
|
|
|||
|
Net income attributable to The Carlyle Group Inc.
|
$
|
$
|
$
|
$
|
|||
|
Net income attributable to The Carlyle Group Inc. per common share (see Note 12)
|
|||||||
|
Basic
|
$
|
$
|
$
|
$
|
|||
|
Diluted
|
$
|
$
|
$
|
$
|
|||
|
Weighted-average common shares
|
|||||||
|
Basic
|
|
|
|
|
|||
|
Diluted
|
|
|
|
|
|||
|
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||
|
|
2025
|
2024
|
2025
|
2024
|
|||
|
Net income
|
$
|
$
|
$
|
$
|
|||
|
Other comprehensive income (loss)
|
|||||||
|
Foreign currency translation adjustments
|
(
|
|
|
|
|||
|
Defined benefit plans
|
|||||||
|
Unrealized income (loss) for the period
|
(
|
|
(
|
|
|||
|
Reclassification adjustment for gain during the period, included in
cash-based compensation and benefits expense
|
(
|
|
(
|
(
|
|||
|
Other comprehensive income (loss)
|
(
|
|
|
|
|||
|
Comprehensive income
|
|
|
|
|
|||
|
Comprehensive income attributable to non-controlling interests in
consolidated entities
|
|
|
|
|
|||
|
Comprehensive income (loss) attributable to The Carlyle Group Inc.
|
$
(
|
$
|
$
|
$
|
|||
|
Common
Shares
|
Common
Stock
|
Additional
Paid-in-
Capital
|
Retained
Earnings
|
Accumulated
Other
Comprehensive
Loss
|
Non-
controlling
Interests in
Consolidated
Entities
|
Total
Equity
|
|||||||
|
Balance at June 30, 2025
|
|
$
|
$
|
$
|
$
(
|
$
|
$
|
||||||
|
Shares repurchased
|
(
|
(
|
—
|
(
|
—
|
—
|
(
|
||||||
|
Net shares issued for equity-based awards
|
|
—
|
—
|
(
|
—
|
—
|
(
|
||||||
|
Equity-based compensation
|
—
|
|
|
—
|
—
|
—
|
|
||||||
|
Dividend-equivalent rights on certain equity-
based awards
|
—
|
—
|
|
(
|
—
|
—
|
|
||||||
|
Contributions
|
—
|
—
|
—
|
—
|
—
|
|
|
||||||
|
Dividends and distributions
|
—
|
—
|
—
|
(
|
—
|
(
|
(
|
||||||
|
Net income
|
—
|
—
|
—
|
|
—
|
|
|
||||||
|
Currency translation adjustments
|
—
|
—
|
—
|
—
|
(
|
(
|
(
|
||||||
|
Defined benefit plans, net
|
—
|
—
|
—
|
—
|
(
|
—
|
(
|
||||||
|
Balance at September 30, 2025
|
|
$
|
$
|
$
|
$
(
|
$
|
$
|
||||||
|
Common
Shares
|
Common
Stock
|
Additional
Paid-in-
Capital
|
Retained
Earnings
|
Accumulated
Other
Comprehensive
Loss
|
Non-
controlling
Interests in
Consolidated
Entities
|
Total
Equity
|
|||||||
|
Balance at December 31, 2024
|
|
$
|
$
|
$
|
$
(
|
$
|
$
|
||||||
|
Shares repurchased
|
(
|
(
|
—
|
(
|
—
|
—
|
(
|
||||||
|
Net shares issued for equity-based awards
|
|
—
|
—
|
(
|
—
|
—
|
(
|
||||||
|
Equity-based compensation
|
—
|
|
|
—
|
—
|
—
|
|
||||||
|
Dividend-equivalent rights on certain equity-
based awards
|
—
|
—
|
|
(
|
—
|
—
|
|
||||||
|
Initial consolidation of a Consolidated Entity
|
—
|
—
|
—
|
—
|
—
|
|
|
||||||
|
Contributions
|
—
|
—
|
—
|
—
|
—
|
|
|
||||||
|
Dividends and distributions
|
—
|
—
|
—
|
(
|
—
|
(
|
(
|
||||||
|
Net income
|
—
|
—
|
—
|
|
—
|
|
|
||||||
|
Currency translation adjustments
|
—
|
—
|
—
|
—
|
|
|
|
||||||
|
Defined benefit plans, net
|
—
|
—
|
—
|
—
|
(
|
—
|
(
|
||||||
|
Balance at September 30, 2025
|
|
$
|
$
|
$
|
$
(
|
$
|
$
|
|
Common
Shares
|
Common
Stock
|
Additional
Paid-in-
Capital
|
Retained
Earnings
|
Accumulated
Other
Comprehensive
Loss
|
Non-
controlling
Interests in
Consolidated
Entities
|
Total
Equity
|
|||||||
|
Balance at June 30, 2024
|
|
$
|
$
|
$
|
$
(
|
$
|
$
|
||||||
|
Shares repurchased
|
(
|
(
|
—
|
(
|
—
|
—
|
(
|
||||||
|
Net shares issued for equity-based awards
|
|
—
|
—
|
(
|
—
|
—
|
(
|
||||||
|
Equity-based compensation
|
—
|
|
|
—
|
—
|
—
|
|
||||||
|
Dividend-equivalent rights on certain equity-
based awards
|
—
|
—
|
|
(
|
—
|
—
|
|
||||||
|
Contributions
|
—
|
—
|
—
|
—
|
—
|
|
|
||||||
|
Dividends and distributions
|
—
|
—
|
—
|
(
|
—
|
(
|
(
|
||||||
|
Net income
|
—
|
—
|
—
|
|
—
|
|
|
||||||
|
Currency translation adjustments
|
—
|
—
|
—
|
—
|
|
|
|
||||||
|
Change in ownership interests of a Consolidated
Entity
|
—
|
—
|
—
|
|
—
|
(
|
|
||||||
|
Defined benefit plans, net
|
—
|
—
|
—
|
—
|
|
—
|
|
||||||
|
Balance at September 30, 2024
|
|
$
|
$
|
$
|
$
(
|
$
|
$
|
||||||
|
Common
Shares
|
Common
Stock
|
Additional
Paid-in-
Capital
|
Retained
Earnings
|
Accumulated
Other
Comprehensive
Loss
|
Non-
controlling
Interests in
Consolidated
Entities
|
Total
Equity
|
|||||||
|
Balance at December 31, 2023
|
|
$
|
$
|
$
|
$
(
|
$
|
$
|
||||||
|
Shares repurchased
|
(
|
(
|
—
|
(
|
—
|
—
|
(
|
||||||
|
Net shares issued for equity-based awards
|
|
—
|
—
|
(
|
—
|
—
|
(
|
||||||
|
Equity-based compensation
|
—
|
|
|
—
|
—
|
—
|
|
||||||
|
Dividend-equivalent rights on certain equity-
based awards
|
—
|
—
|
|
(
|
—
|
—
|
|
||||||
|
Contributions
|
—
|
—
|
—
|
—
|
—
|
|
|
||||||
|
Dividends and distributions
|
—
|
—
|
—
|
(
|
—
|
(
|
(
|
||||||
|
Net income
|
—
|
—
|
—
|
|
—
|
|
|
||||||
|
Currency translation adjustments
|
—
|
—
|
—
|
—
|
|
|
|
||||||
|
Change in ownership interests of a Consolidated
Entity
|
—
|
—
|
—
|
|
—
|
(
|
|
||||||
|
Defined benefit plans, net
|
—
|
—
|
—
|
—
|
|
—
|
|
||||||
|
Balance at September 30, 2024
|
|
$
|
$
|
$
|
$
(
|
$
|
$
|
|
|
Nine Months Ended September 30,
|
||
|
|
2025
|
2024
|
|
|
Cash flows from operating activities
|
|||
|
Net income
|
$
|
$
|
|
|
Adjustments to reconcile net income to net cash flows from operating activities:
|
|||
|
Depreciation and amortization
|
|
|
|
|
Equity-based compensation
|
|
|
|
|
Non-cash performance allocations and incentive fees, net
|
|
(
|
|
|
Non-cash principal investment income
|
(
|
(
|
|
|
Other non-cash amounts
|
|
|
|
|
Consolidated Funds related:
|
|||
|
Realized/unrealized (gain) loss on investments of Consolidated Funds
|
(
|
(
|
|
|
Realized/unrealized (gain) loss from loans payable of Consolidated Funds
|
(
|
|
|
|
Purchases of investments by Consolidated Funds
|
(
|
(
|
|
|
Proceeds from sales and settlements of investments by Consolidated Funds
|
|
|
|
|
Non-cash interest income, net
|
(
|
(
|
|
|
Change in cash and cash equivalents held at Consolidated Funds
|
|
(
|
|
|
Change in other receivables held at Consolidated Funds
|
(
|
(
|
|
|
Change in other liabilities held at Consolidated Funds
|
|
|
|
|
Purchases of investments
|
(
|
(
|
|
|
Proceeds from the sale of investments
|
|
|
|
|
Payments of contingent consideration
|
(
|
(
|
|
|
Changes in deferred taxes, net
|
(
|
|
|
|
Change in due from affiliates and other receivables
|
(
|
(
|
|
|
Change in deposits and other
|
(
|
(
|
|
|
Change in accounts payable, accrued expenses and other liabilities
|
|
|
|
|
Change in accrued compensation and benefits
|
(
|
(
|
|
|
Change in due to affiliates
|
|
(
|
|
|
Change in lease right-of-use assets and lease liabilities
|
(
|
(
|
|
|
Change in deferred revenue
|
|
|
|
|
Net cash used in operating activities
|
(
|
(
|
|
|
Cash flows from investing activities
|
|||
|
Purchases of corporate treasury investments
|
|
(
|
|
|
Proceeds from corporate treasury investments
|
|
|
|
|
Purchases of fixed assets, net
|
(
|
(
|
|
|
Net cash used in investing activities
|
(
|
(
|
|
|
|
Nine Months Ended September 30,
|
||
|
|
2025
|
2024
|
|
|
Cash flows from financing activities
|
|||
|
Borrowings under credit facilities
|
|
|
|
|
Repayments under credit facilities
|
|
(
|
|
|
Issuance of
|
|
|
|
|
Payments on CLO borrowings
|
(
|
(
|
|
|
Proceeds from CLO borrowings, net of financing costs
|
|
|
|
|
Net borrowings on loans payable of Consolidated Funds
|
|
|
|
|
Dividends to common stockholders
|
(
|
(
|
|
|
Payment of deferred consideration for Carlyle Holdings units
|
|
(
|
|
|
Contributions from non-controlling interest holders
|
|
|
|
|
Distributions to non-controlling interest holders
|
(
|
(
|
|
|
Common shares repurchased and net share settlement of equity-based awards
|
(
|
(
|
|
|
Change in due to/from affiliates financing activities
|
|
|
|
|
Net cash provided by financing activities
|
|
|
|
|
Effect of foreign exchange rate changes
|
|
|
|
|
Increase (decrease) in cash, cash equivalents and restricted cash
|
|
(
|
|
|
Cash, cash equivalents and restricted cash, beginning of period
|
|
|
|
|
Cash, cash equivalents and restricted cash, end of period
|
$
|
$
|
|
|
Supplemental non-cash disclosures
|
|||
|
Initial consolidation of Consolidated Funds
|
$
|
$
|
|
|
Net asset impact of deconsolidation of Consolidated Funds
|
$
(
|
$
(
|
|
|
Reconciliation of cash, cash equivalents and restricted cash, end of period:
|
|||
|
Cash and cash equivalents
|
$
|
$
|
|
|
Restricted cash
|
|
|
|
|
Total cash, cash equivalents and restricted cash, end of period
|
$
|
$
|
|
|
Cash and cash equivalents held at Consolidated Funds
|
$
|
$
|
|
|
|
As of
|
||
|
|
September 30,
2025
|
December 31,
2024
|
|
|
|
(Dollars in millions)
|
||
|
Investments
|
$
|
$
|
|
|
Accrued performance allocations
|
|
|
|
|
Management fee receivables
|
|
|
|
|
Total
|
$
|
$
|
|
|
|
As of
|
||
|
|
September 30,
2025
|
December 31,
2024
|
|
|
|
(Dollars in millions)
|
||
|
Currency translation adjustments
|
$
(
|
$
(
|
|
|
Unrealized losses on defined benefit plans
|
(
|
(
|
|
|
Total
|
$
(
|
$
(
|
|
|
(Dollars in millions)
|
Level I
|
Level II
|
Level III
|
Total
|
|||
|
Assets
|
|||||||
|
Investments of Consolidated Funds
(1)
:
|
|||||||
|
Equity securities
(2)
|
$
|
$
|
$
|
$
|
|||
|
Bonds
|
|
|
|
|
|||
|
Loans
|
|
|
|
|
|||
|
|
|
|
|
||||
|
Investments in CLOs and other:
|
|||||||
|
Investments in CLOs
|
|
|
|
|
|||
|
Other investments
(3)
|
|
|
|
|
|||
|
Foreign currency forward contracts
|
|
|
|
|
|||
|
Subtotal
|
$
|
$
|
$
|
$
|
|||
|
Investments measured at net asset value
|
|
||||||
|
Total
|
$
|
||||||
|
Liabilities
|
|||||||
|
Loans payable of Consolidated Funds
(4)(5)
|
$
|
$
|
$
|
$
|
|||
|
Foreign currency forward contracts
|
|
|
|
|
|||
|
Total
|
$
|
$
|
$
|
$
|
|
(Dollars in millions)
|
Level I
|
Level II
|
Level III
|
Total
|
|||
|
Assets
|
|||||||
|
Investments of Consolidated Funds
(1)
:
|
|||||||
|
Equity securities
(2)
|
$
|
$
|
$
|
$
|
|||
|
Bonds
|
|
|
|
|
|||
|
Loans
|
|
|
|
|
|||
|
Other
|
|
|
|
|
|||
|
|
|
|
|
||||
|
Investments in CLOs and other:
|
|||||||
|
Investments in CLOs
|
|
|
|
|
|||
|
Other investments
(3)
|
|
|
|
|
|||
|
|
|
|
|
||||
|
Subtotal
|
$
|
$
|
$
|
$
|
|||
|
Investments measured at net asset value
|
|
||||||
|
Total
|
$
|
||||||
|
Liabilities
|
|||||||
|
Loans payable of Consolidated Funds
(4)(5)
|
$
|
$
|
$
|
$
|
|||
|
Foreign currency forward contracts
|
|
|
|
|
|||
|
Total
|
$
|
$
|
$
|
$
|
|
Financial Assets
|
|||||||||||
|
Three Months Ended September 30, 2025
|
|||||||||||
|
|
Investments of Consolidated Funds
|
|
|
||||||||
|
|
Equity
securities
|
Bonds
|
Loans
|
Investments in
CLOs
|
Other
investments
|
Total
|
|||||
|
Balance, beginning of period
|
$
|
$
|
$
|
$
|
$
|
$
|
|||||
|
Initial consolidation/deconsolidation of funds
(1)
|
|
(
|
(
|
(
|
|
(
|
|||||
|
Purchases
|
|
|
|
|
|
|
|||||
|
Sales and distributions
|
(
|
(
|
(
|
(
|
(
|
(
|
|||||
|
Settlements
|
|
|
(
|
|
|
(
|
|||||
|
Realized and unrealized gains (losses), net
|
|||||||||||
|
Included in earnings
|
(
|
|
(
|
|
(
|
(
|
|||||
|
Included in other comprehensive income
|
|
(
|
(
|
(
|
|
(
|
|||||
|
Balance, end of period
|
$
|
$
|
$
|
$
|
$
|
$
|
|||||
|
Changes in unrealized gains (losses) included in earnings
related to financial assets still held at the reporting date
|
$
(
|
$
|
$
(
|
$
|
$
(
|
$
(
|
|||||
|
Changes in unrealized gains (losses) included in other
comprehensive income related to financial assets still held at
the reporting date
|
$
|
$
|
$
|
$
(
|
$
|
$
(
|
|||||
|
Financial Assets
|
|||||||||||
|
Nine Months Ended September 30, 2025
|
|||||||||||
|
|
Investments of Consolidated Funds
|
|
|
||||||||
|
|
Equity
securities
|
Bonds
|
Loans
|
Investments in
CLOs
|
Other
investments
|
Total
|
|||||
|
Balance, beginning of period
|
$
|
$
|
$
|
$
|
$
|
$
|
|||||
|
Initial consolidation/deconsolidation of funds
(2)
|
|
(
|
(
|
|
|
(
|
|||||
|
Transfer out related to the Exchange
(3)
|
|
|
|
|
(
|
(
|
|||||
|
Purchases
|
|
|
|
|
|
|
|||||
|
Sales and distributions
|
(
|
(
|
(
|
(
|
(
|
(
|
|||||
|
Settlements
|
|
(
|
(
|
|
|
(
|
|||||
|
Realized and unrealized gains (losses), net
|
|||||||||||
|
Included in earnings
|
|
|
(
|
|
|
(
|
|||||
|
Included in other comprehensive income
|
|
|
|
|
|
|
|||||
|
Balance, end of period
|
$
|
$
|
$
|
$
|
$
|
$
|
|||||
|
Changes in unrealized gains (losses) included in earnings
related to financial assets still held at the reporting date
|
$
(
|
$
|
$
(
|
$
|
$
|
$
(
|
|||||
|
Changes in unrealized gains (losses) included in other
comprehensive income related to financial assets still held at
the reporting date
|
$
|
$
|
$
|
$
|
$
|
$
|
|||||
|
Financial Assets
|
|||||||||||
|
Three Months Ended September 30, 2024
|
|||||||||||
|
Investments of Consolidated Funds
|
|||||||||||
|
Equity
securities
|
Bonds
|
Loans
|
Investments in
CLOs
|
Other
investments
|
Total
|
||||||
|
Balance, beginning of period
|
$
|
$
|
$
|
$
|
$
|
$
|
|||||
|
Deconsolidation of funds
(1)
|
|
(
|
(
|
|
|
(
|
|||||
|
Purchases
|
|
|
|
|
|
|
|||||
|
Sales and distributions
|
(
|
(
|
(
|
(
|
(
|
(
|
|||||
|
Settlements
|
|
|
(
|
|
|
(
|
|||||
|
Realized and unrealized gains (losses), net
|
|||||||||||
|
Included in earnings
|
(
|
|
(
|
(
|
(
|
(
|
|||||
|
Included in other comprehensive income
|
|
|
|
|
|
|
|||||
|
Balance, end of period
|
$
|
$
|
$
|
$
|
$
|
$
|
|||||
|
Changes in unrealized gains (losses) included in earnings
related to financial assets still held at the reporting date
|
$
(
|
$
|
$
(
|
$
(
|
$
(
|
$
(
|
|||||
|
Changes in unrealized gains (losses) included in other
comprehensive income related to financial assets still held at
the reporting date
|
$
|
$
|
$
|
$
|
$
|
$
|
|||||
|
Financial Assets
|
|||||||||||
|
Nine Months Ended September 30, 2024
|
|||||||||||
|
|
Investments of Consolidated Funds
|
|
|
||||||||
|
|
Equity
securities
|
Bonds
|
Loans
|
Investments in
CLOs
|
Other
investments
|
Total
|
|||||
|
Balance, beginning of period
|
$
|
$
|
$
|
$
|
$
|
$
|
|||||
|
Deconsolidation of funds
(1)
|
|
(
|
(
|
|
|
(
|
|||||
|
Purchases
|
|
|
|
|
|
|
|||||
|
Sales and distributions
|
(
|
(
|
(
|
(
|
(
|
(
|
|||||
|
Settlements
|
|
|
(
|
|
|
(
|
|||||
|
Realized and unrealized gains (losses), net
|
|||||||||||
|
Included in earnings
|
(
|
|
|
|
(
|
|
|||||
|
Included in other comprehensive income
|
|
|
|
|
|
|
|||||
|
Balance, end of period
|
$
|
$
|
$
|
$
|
$
|
$
|
|||||
|
Changes in unrealized gains (losses) included in earnings
related to financial assets still held at the reporting date
|
$
(
|
$
|
$
|
$
|
$
(
|
$
(
|
|||||
|
Changes in unrealized gains (losses) included in other
comprehensive income related to financial assets still held at
the reporting date
|
$
|
$
|
$
|
$
|
$
|
$
|
|||||
|
Financial Liabilities
|
|||
|
Loans Payable of Consolidated Funds
|
|||
|
Three Months Ended September 30,
|
|||
|
|
2025
|
2024
|
|
|
Balance, beginning of period
|
$
|
$
|
|
|
Initial consolidation/deconsolidation of funds
(1)
|
(
|
(
|
|
|
Borrowings
|
|
|
|
|
Paydowns
|
(
|
(
|
|
|
Sales
|
(
|
|
|
|
Realized and unrealized (gains) losses, net
|
|||
|
Included in earnings
|
(
|
(
|
|
|
Included in other comprehensive income
|
(
|
|
|
|
Balance, end of period
|
$
|
$
|
|
|
Changes in unrealized (gains) losses included in earnings related to
financial liabilities still held at the reporting date
|
$
(
|
$
(
|
|
|
Changes in unrealized (gains) losses included in other comprehensive
income related to financial liabilities still held at the reporting date
|
$
|
$
|
|
|
Financial Liabilities
|
|||
|
Loans Payable of Consolidated Funds
|
|||
|
|
Nine Months Ended September 30,
|
||
|
|
2025
|
2024
|
|
|
Balance, beginning of period
|
$
|
$
|
|
|
Initial consolidation/deconsolidation of funds
(2)
|
(
|
(
|
|
|
Borrowings
|
|
|
|
|
Paydowns
|
(
|
(
|
|
|
Sales
|
(
|
(
|
|
|
Realized and unrealized (gains) losses, net
|
|||
|
Included in earnings
|
(
|
|
|
|
Included in other comprehensive income
|
|
|
|
|
Balance, end of period
|
$
|
$
|
|
|
Changes in unrealized (gains) losses included in earnings related to
financial liabilities still held at the reporting date
|
$
(
|
$
|
|
|
Changes in unrealized (gains) losses included in other comprehensive
income related to financial liabilities still held at the reporting date
|
$
|
$
|
|
|
Fair Value at
|
Valuation Technique(s)
|
Unobservable Input(s)
|
Range
(Weighted Average)
|
Impact to
Valuation
from Increase
in Input
|
|||||
|
(Dollars in millions)
|
September 30,
2025
|
||||||||
|
Assets
|
|||||||||
|
Investments of Consolidated
Funds:
|
|||||||||
|
Equity securities
|
$
|
Consensus Pricing
|
Indicative Quotes ($ per share)
|
|
Higher
|
||||
|
|
Discounted Cash Flow
|
Discount Rates
|
|
Lower
|
|||||
|
Terminal Growth Rate
|
|
Higher
|
|||||||
|
Comparable Multiple
|
EBITDA Multiple
|
|
Higher
|
||||||
|
TCF Multiple
|
|
Higher
|
|||||||
|
|
Comparable Multiple
|
Market Approach
|
|
Higher
|
|||||
|
|
Discounted Cash Flow
|
Discount Rates
|
|
Lower
|
|||||
|
Constant Prepayment Rate
|
|
Lower
|
|||||||
|
Constant Default Rate
|
|
Lower
|
|||||||
|
Recovery Rate
|
|
Higher
|
|||||||
|
|
Other
(1)
|
N/A
|
N/A
|
N/A
|
|||||
|
Bonds
|
|
Consensus Pricing
|
Indicative Quotes (% of Par)
|
|
Higher
|
||||
|
Loans
|
|
Consensus Pricing
|
Indicative Quotes (% of Par)
|
|
Higher
|
||||
|
|
Discounted Cash Flow
|
Discount Rates
|
|
Lower
|
|||||
|
|
Discounted Cash Flow
|
Discount Rates
|
|
Lower
|
|||||
|
Constant Prepayment Rate
|
|
Lower
|
|||||||
|
Constant Default Rate
|
|
Lower
|
|||||||
|
Recovery Rate
|
|
Higher
|
|||||||
|
|
Other
(1)
|
N/A
|
N/A
|
N/A
|
|||||
|
|
|||||||||
|
Investments in CLOs:
|
|||||||||
|
Senior secured notes
|
|
Consensus Pricing with
Discounted Cash Flow
|
Indicative Quotes (% of Par)
|
|
Higher
|
||||
|
Discount Margins (Basis
Points)
|
|
Lower
|
|||||||
|
Default Rates
|
|
Lower
|
|||||||
|
Recovery Rates
|
|
Higher
|
|||||||
|
Subordinated notes and
preferred shares
|
|
Consensus Pricing with
Discounted Cash Flow
|
Indicative Quotes (% of Par)
|
|
Higher
|
||||
|
Discount Rates
|
(
|
Lower
|
|||||||
|
Default Rates
|
|
Lower
|
|||||||
|
Recovery Rates
|
|
Higher
|
|||||||
|
Other investments:
|
|||||||||
|
Aviation subordinated
notes
|
|
Discounted Cash Flow
|
Discount Rates
|
|
Lower
|
||||
|
|
Other
(1)
|
N/A
|
N/A
|
N/A
|
|||||
|
Total
|
$
|
||||||||
|
Liabilities
|
|||||||||
|
Loans payable of Consolidated
Funds:
|
|||||||||
|
Senior secured notes
|
$
|
Other
(2)
|
N/A
|
N/A
|
N/A
|
||||
|
Subordinated notes and
preferred shares
|
|
Consensus Pricing with
Discounted Cash Flow
|
Indicative Quotes (% of Par)
|
|
Higher
|
||||
|
Discount Rates
|
|
Lower
|
|||||||
|
Default Rates
|
|
Lower
|
|||||||
|
Recovery Rates
|
|
Higher
|
|||||||
|
Total
|
$
|
|
Fair Value at
|
Valuation Technique(s)
|
Unobservable Input(s)
|
Range
(Weighted Average)
|
Impact to
Valuation
from
Increase in
Input
|
|||||
|
(Dollars in millions)
|
December 31, 2024
|
||||||||
|
Assets
|
|||||||||
|
Investments of Consolidated
Funds:
|
|||||||||
|
Equity securities
|
$
|
Consensus Pricing
|
Indicative Quotes ($ per share)
|
|
Higher
|
||||
|
|
Discounted Cash Flow
|
Discount Rates
|
|
Lower
|
|||||
|
Terminal Growth Rate
|
|
Higher
|
|||||||
|
Comparable Multiple
|
EBITDA Multiple
|
|
Higher
|
||||||
|
TCF Multiple
|
|
Higher
|
|||||||
|
|
Discounted Cash Flow
|
Discount Rates
|
|
Lower
|
|||||
|
Constant Prepayment Rate
|
|
Lower
|
|||||||
|
Constant Default Rate
|
|
Lower
|
|||||||
|
Recovery Rate
|
|
Higher
|
|||||||
|
|
Other
(1)
|
N/A
|
N/A
|
N/A
|
|||||
|
Bonds
|
|
Consensus Pricing
|
Indicative Quotes (% of Par)
|
|
Higher
|
||||
|
Loans
|
|
Consensus Pricing
|
Indicative Quotes (% of Par)
|
|
Higher
|
||||
|
|
Discounted Cash Flow
|
Discount Rates
|
|
Lower
|
|||||
|
|
Discounted Cash Flow
|
Discount Rates
|
|
Lower
|
|||||
|
Constant Prepayment Rate
|
|
Lower
|
|||||||
|
Constant Default Rate
|
|
Lower
|
|||||||
|
Recovery Rate
|
|
Higher
|
|||||||
|
Other
|
|
Other
(1)
|
N/A
|
N/A
|
N/A
|
||||
|
|
|||||||||
|
Investments in CLOs
|
|||||||||
|
Senior secured notes
|
|
Discounted Cash Flow
with Consensus Pricing
|
Indicative Quotes (% of Par)
|
|
Higher
|
||||
|
Discount Margins (Basis
Points)
|
|
Lower
|
|||||||
|
Default Rates
|
|
Lower
|
|||||||
|
Recovery Rates
|
|
Higher
|
|||||||
|
Subordinated notes and
preferred shares
|
|
Discounted Cash Flow
with Consensus Pricing
|
Indicative Quotes (% of Par)
|
|
Higher
|
||||
|
Discount Rate
|
|
Lower
|
|||||||
|
Default Rates
|
|
Lower
|
|||||||
|
Recovery Rates
|
|
Higher
|
|||||||
|
Other investments:
|
|||||||||
|
BDC preferred shares
|
|
Other
(2)
|
Net Asset Value per Share
|
|
Lower
|
||||
|
Aviation subordinated
notes
|
|
Discounted Cash Flow
|
Discount Rates
|
|
Lower
|
||||
|
Loans
|
|
Consensus Pricing
|
Indicative Quotes (% of Par)
|
|
Higher
|
||||
|
Total
|
$
|
||||||||
|
Liabilities
|
|||||||||
|
Loans payable of Consolidated
Funds:
|
|||||||||
|
Senior secured notes
|
$
|
Other
(3)
|
N/A
|
N/A
|
N/A
|
||||
|
Subordinated notes and
preferred shares
|
|
Discounted Cash Flow
with Consensus Pricing
|
Indicative Quotes (% of Par)
|
|
Higher
|
||||
|
Discount Rates
|
|
Lower
|
|||||||
|
Default Rates
|
|
Lower
|
|||||||
|
Recovery Rates
|
|
Higher
|
|||||||
|
Total
|
$
|
|
|
As of
|
||
|
|
September 30,
2025
|
December 31,
2024
|
|
|
|
(Dollars in millions)
|
||
|
Accrued performance allocations
|
$
|
$
|
|
|
Principal equity method investments, excluding performance allocations
|
|
|
|
|
Principal investments in CLOs
|
|
|
|
|
Other investments
|
|
|
|
|
Total
|
$
|
$
|
|
|
|
As of
|
||
|
|
September 30,
2025
|
December 31,
2024
|
|
|
|
(Dollars in millions)
|
||
|
Global Private Equity
|
$
|
$
|
|
|
Global Credit
|
|
|
|
|
Carlyle AlpInvest
|
|
|
|
|
Total
|
$
|
$
|
|
|
|
As of
|
||
|
|
September 30,
2025
|
December 31,
2024
|
|
|
|
(Dollars in millions)
|
||
|
Global Private Equity
|
$
(
|
$
(
|
|
|
Global Credit
|
(
|
(
|
|
|
Total
|
$
(
|
$
(
|
|
|
|
As of
|
||
|
|
September 30,
2025
|
December 31,
2024
|
|
|
|
(Dollars in millions)
|
||
|
Global Private Equity
(1)
|
$
|
$
|
|
|
Global Credit
(2)
|
|
|
|
|
Carlyle AlpInvest
|
|
|
|
|
Total
|
$
|
$
|
|
|
As of
|
|||
|
September 30,
2025
|
December 31,
2024
|
||
|
(Dollars in millions)
|
|||
|
Investment in NGP Management
|
$
|
$
|
|
|
Investments in NGP general partners - accrued performance allocations
|
|
|
|
|
Principal investments in NGP funds
|
|
|
|
|
Total investments in NGP
|
$
|
$
|
|
|
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||
|
|
2025
|
2024
|
2025
|
2024
|
|||
|
|
(Dollars in millions)
|
||||||
|
Management fee related revenues from NGP Management
|
$
|
$
|
$
|
$
|
|||
|
Expenses related to the investment in NGP Management
|
(
|
(
|
(
|
(
|
|||
|
Amortization of basis differences and impairment of investment in NGP
Management
|
(
|
|
(
|
|
|||
|
Net investment income from NGP Management
|
$
|
$
|
$
(
|
$
|
|||
|
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||
|
|
2025
|
2024
|
2025
|
2024
|
|||
|
|
(Dollars in millions)
|
||||||
|
Performance allocations
|
|||||||
|
Realized
|
$
|
$
|
$
|
$
|
|||
|
Unrealized
|
(
|
|
(
|
|
|||
|
(
|
|
|
|
||||
|
Principal investment income (loss) from equity method investments
(excluding performance allocations)
|
|||||||
|
Realized
|
|
|
|
|
|||
|
Unrealized
|
|
|
(
|
|
|||
|
|
|
|
|
||||
|
Principal investment income (loss) from investments in CLOs and other
investments
|
|||||||
|
Realized
|
|
(
|
|
|
|||
|
Unrealized
(1)
|
|
(
|
|
(
|
|||
|
|
(
|
|
|
||||
|
Total
|
$
(
|
$
|
$
|
$
|
|||
|
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||
|
|
2025
|
2024
|
2025
|
2024
|
|||
|
|
(Dollars in millions)
|
||||||
|
Global Private Equity
|
$
(
|
$
|
$
(
|
$
|
|||
|
Global Credit
|
|
|
|
|
|||
|
Carlyle AlpInvest
|
|
|
|
|
|||
|
Total
|
$
(
|
$
|
$
|
$
|
|||
|
Three Months Ended September 30, 2025
|
Nine Months Ended September 30, 2025
|
|||||
|
(Dollars in millions)
|
(Dollars in millions)
|
|||||
|
Global Private Equity
|
Carlyle Asia Partners V, L.P.
|
$
(
|
Global Private Equity
|
Carlyle Partners VII, L.P.
|
$
(
|
|
|
Global Private Equity
|
Carlyle Partners VII, L.P.
|
(
|
Global Private Equity
|
Carlyle Asia Partners V, L.P.
|
(
|
|
|
Three Months Ended September 30, 2024
|
Nine Months Ended September 30, 2024
|
|||||
|
(Dollars in millions)
|
(Dollars in millions)
|
|||||
|
Global Private Equity
|
Carlyle Partners VII, L.P.
|
$
|
Global Private Equity
|
Carlyle Partners VII, L.P.
|
$
|
|
|
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||
|
|
2025
|
2024
|
2025
|
2024
|
|||
|
|
(Dollars in millions)
|
||||||
|
Global Private Equity
|
$
|
$
|
$
(
|
$
|
|||
|
Global Credit
|
|
|
|
|
|||
|
Carlyle AlpInvest
|
|
|
|
|
|||
|
Total
|
$
|
$
|
$
|
$
|
|||
|
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||
|
|
2025
|
2024
|
2025
|
2024
|
|||
|
|
(Dollars in millions)
|
||||||
|
Interest income from investments
|
$
|
$
|
$
|
$
|
|||
|
Other income
|
|
|
|
|
|||
|
Total
|
$
|
$
|
$
|
$
|
|||
|
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||
|
|
2025
|
2024
|
2025
|
2024
|
|||
|
|
(Dollars in millions)
|
||||||
|
Gains (losses) from investments of Consolidated Funds
|
$
|
$
(
|
$
|
$
|
|||
|
Gains (losses) from liabilities of CLOs
|
|
|
|
(
|
|||
|
Total
|
$
|
$
|
$
|
$
(
|
|||
|
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||
|
|
2025
|
2024
|
2025
|
2024
|
|||
|
|
(Dollars in millions)
|
||||||
|
Realized gains (losses)
|
$
|
$
(
|
$
|
$
(
|
|||
|
Net change in unrealized gains (losses)
|
|
(
|
|
|
|||
|
Total
|
$
|
$
(
|
$
|
$
|
|||
|
As of
|
|||
|
September 30,
2025
|
December 31,
2024
|
||
|
(Dollars in millions)
|
|||
|
Acquired contractual rights
|
$
|
$
|
|
|
Accumulated amortization
|
(
|
(
|
|
|
Finite-lived intangible assets, net
|
|
|
|
|
Goodwill
|
|
|
|
|
Intangible Assets, net
|
$
|
$
|
|
|
Year ending December 31,
|
|
|
2025 (excluding the nine months ended September 30, 2025)
|
$
|
|
2026
|
|
|
2027
|
|
|
2028
|
|
|
2029
|
|
|
Thereafter
|
|
|
$
|
|
|
September 30, 2025
|
December 31, 2024
|
|||||
|
|
Borrowing
Outstanding
|
Carrying
Value
|
Borrowing
Outstanding
|
Carrying
Value
|
|||
|
(Dollars in millions)
|
|||||||
|
CLO Borrowings
(See below)
|
$
|
$
|
$
|
$
|
|||
|
|
|
|
|
|
|||
|
|
|
|
|
|
|||
|
|
|
|
|
|
|||
|
|
|
|
|
|
|||
|
|
|
|
|
|
|||
|
Total debt obligations
|
$
|
$
|
$
|
$
|
|||
|
Formation Date
|
Borrowing
Outstanding
September 30,
2025
|
Borrowing
Outstanding
December 31, 2024
|
Maturity Date (1)
|
Interest Rate as of
September 30, 2025
|
|||||||
|
February 28, 2017
|
$
|
$
|
September 21, 2029
|
|
(2)
|
||||||
|
December 6, 2017
|
|
|
N/A
|
N/A
|
(5)
|
||||||
|
March 15, 2019
|
|
|
March 15, 2032
|
|
(3)
|
||||||
|
August 20, 2019
|
|
|
August 15, 2032
|
|
(3)
|
||||||
|
September 15, 2020
|
|
|
April 15, 2033
|
|
(3)
|
||||||
|
January 8, 2021
|
|
|
January 15, 2034
|
|
(3)
|
||||||
|
March 30, 2021
|
|
|
March 15, 2032
|
|
(3)
|
||||||
|
April 21, 2021
|
|
|
April 15, 2033
|
|
(3)
|
||||||
|
May 21, 2021
|
|
|
November 17, 2031
|
|
(3)
|
||||||
|
June 4, 2021
|
|
|
January 16, 2034
|
|
(3)
|
||||||
|
June 10, 2021
|
|
|
November 17, 2031
|
|
(3)
|
||||||
|
July 15, 2021
|
|
|
July 15, 2034
|
|
(3)
|
||||||
|
July 20, 2021
|
|
|
July 20, 2034
|
|
(3)
|
||||||
|
August 4, 2021
|
|
|
August 15, 2032
|
|
(3)
|
||||||
|
October 27, 2021
|
|
|
October 15, 2035
|
|
(3)
|
||||||
|
January 6, 2022
|
|
|
February 15, 2035
|
|
(3)
|
||||||
|
February 22, 2022
|
|
|
November 10, 2035
|
|
(3)
|
||||||
|
September 5, 2023
|
|
|
N/A
|
N/A
|
(5)
|
||||||
|
April 25, 2024
|
|
|
April 25, 2037
|
|
(3)
|
||||||
|
December 19, 2024
|
|
|
January 15, 2039
|
|
(3)
|
||||||
|
March 10, 2025
|
|
|
April 15, 2038
|
|
(3)
|
||||||
|
July 10, 2025
|
|
|
August 15, 2038
|
|
(4)
|
||||||
|
August 19, 2025
|
|
|
October 15, 2038
|
|
(4)
|
||||||
|
$
|
$
|
|
Interest Expense
|
|||||||||||||
|
Fair Value
(1)
As of
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||||||||
|
Aggregate
Principal
Amount
|
September
30, 2025
|
December
31, 2024
|
2025
|
2024
|
2025
|
2024
|
|||||||
|
|
$
|
$
|
$
|
$
|
$
|
$
|
$
|
||||||
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
||||||
|
$
|
$
|
$
|
$
|
||||||||||
|
|
As of September 30, 2025
|
||||||||
|
|
Borrowing
Outstanding
|
Fair Value
|
Weighted
Average
Interest Rate
|
|
Weighted
Average
Remaining
Maturity in
Years
|
||||
|
Senior secured notes
(1)
|
$
|
$
|
|
|
|||||
|
Subordinated notes
|
|
|
N/A
|
(3)
|
|
||||
|
Revolving credit facilities
(2)
|
|
|
|
|
|||||
|
Total
|
$
|
$
|
|||||||
|
|
As of December 31, 2024
|
||||||||
|
|
Borrowing
Outstanding
|
Fair Value
|
Weighted
Average
Interest Rate
|
|
Weighted
Average
Remaining
Maturity in
Years
|
||||
|
Senior secured notes
|
$
|
$
|
|
|
|||||
|
Subordinated notes
|
|
|
N/A
|
(3)
|
|
||||
|
Revolving credit facilities
(2)
|
|
|
|
|
|||||
|
Total
|
$
|
$
|
|||||||
|
|
As of
|
||
|
|
September 30,
2025
|
December 31,
2024
|
|
|
|
(Dollars in millions)
|
||
|
Accrued performance allocations and incentive fee related compensation
|
$
|
$
|
|
|
Accrued bonuses
|
|
|
|
|
Realized performance allocations and incentive fee related compensation not yet paid
|
|
|
|
|
Other
|
|
|
|
|
Total
|
$
|
$
|
|
|
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||
|
|
2025
|
2024
|
2025
|
2024
|
|||
|
|
(Dollars in millions)
|
||||||
|
Realized
|
$
|
$
|
$
|
$
|
|||
|
Unrealized
|
(
|
|
(
|
|
|||
|
Total
|
$
(
|
$
|
$
|
$
|
|||
|
|
As of
|
||
|
|
September 30,
2025
|
December 31,
2024
|
|
|
|
(Dollars in millions)
|
||
|
Accrued incentive fees
|
$
|
$
|
|
|
Unbilled receivable for giveback obligations from current and former employees
|
|
|
|
|
Notes receivable and accrued interest from affiliates
|
|
|
|
|
Management fee receivable, net
|
|
|
|
|
Reimbursable expenses and other receivables from unconsolidated funds and affiliates, net
|
|
|
|
|
Total
|
$
|
$
|
|
|
|
As of
|
||
|
|
September 30,
2025
|
December 31,
2024
|
|
|
|
(Dollars in millions)
|
||
|
Due to affiliates of Consolidated Funds
|
$
|
$
|
|
|
Due to non-consolidated affiliates
|
|
|
|
|
Amounts owed under the tax receivable agreement
|
|
|
|
|
Other
|
|
|
|
|
Total
|
$
|
$
|
|
|
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||
|
|
2025
|
2024
|
2025
|
2024
|
|||
|
|
(Dollars in millions)
|
||||||
|
Provision (benefit) for income taxes
|
$
(
|
$
|
$
|
$
|
|||
|
Effective tax rate
|
(
|
|
|
|
|||
|
|
As of
|
||
|
|
September
30, 2025
|
December 31,
2024
|
|
|
|
(Dollars in millions)
|
||
|
Non-Carlyle interests in Consolidated Funds
|
$
|
$
|
|
|
Non-Carlyle interests in majority-owned subsidiaries
|
|
|
|
|
Non-controlling interest in carried interest, giveback obligations and cash held for carried
interest distributions
|
|
(
|
|
|
Non-controlling interests in consolidated entities
|
$
|
$
|
|
|
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||
|
|
2025
|
2024
|
2025
|
2024
|
|||
|
|
(Dollars in millions)
|
||||||
|
Non-Carlyle interests in Consolidated Funds
|
$
|
$
|
$
|
$
|
|||
|
Non-Carlyle interests in majority-owned subsidiaries
|
|
|
|
|
|||
|
Non-controlling interest in carried interest, giveback obligations and
cash held for carried interest distributions
|
|
|
(
|
|
|||
|
Non-controlling interests in income of consolidated entities
|
$
|
$
|
$
|
$
|
|||
|
|
Three Months Ended
September 30, 2025
|
Nine Months Ended
September 30, 2025
|
|||||
|
|
Basic
|
Diluted
|
Basic
|
Diluted
|
|||
|
Net income attributable to common shares
|
$
|
$
|
$
|
$
|
|||
|
Weighted-average common shares outstanding
|
|
|
|
|
|||
|
Net income per common share
|
$
|
$
|
$
|
$
|
|||
|
Three Months Ended
September 30, 2024
|
Nine Months Ended
September 30, 2024
|
||||||
|
Basic
|
Diluted
|
Basic
|
Diluted
|
||||
|
Net income attributable to common shares
|
$
|
$
|
$
|
$
|
|||
|
Weighted-average common shares outstanding
|
|
|
|
|
|||
|
Net income per common share
|
$
|
$
|
$
|
$
|
|||
|
|
Three Months Ended
September 30, 2025
|
Nine Months Ended
September 30, 2025
|
|||||
|
|
Basic
|
Diluted
|
Basic
|
Diluted
|
|||
|
The Carlyle Group Inc. weighted-average common shares outstanding
|
|
|
|
|
|||
|
Unvested restricted stock units
|
|
|
|
|
|||
|
Issuable common shares and performance-vesting restricted stock units
|
|
|
|
|
|||
|
Weighted-average common shares outstanding
|
|
|
|
|
|||
|
Three Months Ended
September 30, 2024
|
Nine Months Ended
September 30, 2024
|
||||||
|
Basic
|
Diluted
|
Basic
|
Diluted
|
||||
|
The Carlyle Group Inc. weighted-average common shares outstanding
|
|
|
|
|
|||
|
Unvested restricted stock units
|
|
|
|
|
|||
|
Issuable common shares and performance-vesting restricted stock units
|
|
|
|
|
|||
|
Weighted-average common shares outstanding
|
|
|
|
|
|||
|
Three Months Ended September 30,
|
Nine Months Ended September 30,
|
||||||||||
|
2025
|
2024
|
2025
|
2024
|
||||||||
|
Shares
|
$
|
Shares
|
$
|
Shares
|
$
|
Shares
|
$
|
||||
|
(Dollars in millions, except share data)
|
|||||||||||
|
Shares repurchased
|
|
$
|
|
$
|
|
$
|
|
$
|
|||
|
Shares retired in connection with the
net share settlement of equity-based
awards
|
|
|
|
|
|
|
|
|
|||
|
Total
|
|
$
|
|
$
|
|
$
|
|
$
|
|||
|
Dividend Record Date
|
Dividend Payment Date
|
Dividend per Common
Share
|
Dividend to Common
Stockholders
|
|||
|
(Dollars in millions, except per share data)
|
||||||
|
May 14, 2024
|
May 21, 2024
|
$
|
$
|
|||
|
August 16, 2024
|
August 26, 2024
|
|
|
|||
|
November 18, 2024
|
November 25, 2024
|
|
|
|||
|
February 21, 2025
|
February 28, 2025
|
|
|
|||
|
Total 2024 Dividend Year
|
$
|
$
|
||||
|
May 19, 2025
|
May 27, 2025
|
$
|
$
|
|||
|
August 18, 2025
|
August 28, 2025
|
|
|
|||
|
November 10, 2025
|
November 19, 2025
|
|
|
|||
|
Total 2025 Dividend Year (through Q3 2025)
|
$
|
$
|
||||
|
Unvested Shares
|
Performance-
Vesting
Restricted
Stock Units
|
Weighted-
Average
Grant Date
Fair Value
|
Restricted
Stock
Units
|
Weighted-
Average
Grant Date
Fair Value
|
Unvested
Common
Shares
|
Weighted-
Average
Grant Date
Fair Value
|
|||||
|
Balance, December 31, 2024
|
|
$
|
|
$
|
|
$
|
|||||
|
Granted
(1)
|
|
$
|
|
$
|
|
$
|
|||||
|
Vested
(2)
|
|
$
|
|
$
|
|
$
|
|||||
|
Forfeited
|
|
$
|
|
$
|
|
$
|
|||||
|
Balance, September 30, 2025
|
|
$
|
|
$
|
|
$
|
|
Three Months Ended September 30, 2025
|
|||||||
|
Global
Private
Equity
|
Global
Credit
|
Carlyle
AlpInvest
|
Total
|
||||
|
(Dollars in millions)
|
|||||||
|
Segment Revenues
|
|||||||
|
Fund level fee revenues
|
|||||||
|
Fund management fees
|
$
|
$
|
$
|
$
|
|||
|
Portfolio advisory and transaction fees, net and other
|
|
|
|
|
|||
|
Fee related performance revenues
|
|
|
|
|
|||
|
Total fund level fee revenues
|
|
|
|
|
|||
|
Realized performance revenues
|
|
|
|
|
|||
|
Realized principal investment income (loss)
|
(
|
|
|
|
|||
|
Interest income
|
|
|
|
|
|||
|
Total revenues
|
|
|
|
|
|||
|
Segment Expenses
|
|||||||
|
Compensation and benefits
|
|||||||
|
Cash-based compensation and benefits
|
|
|
|
|
|||
|
Realized performance revenues related compensation
|
|
|
|
|
|||
|
Total compensation and benefits
|
|
|
|
|
|||
|
General, administrative, and other indirect expenses
(1)
|
|
|
|
|
|||
|
Depreciation and amortization expense
|
|
|
|
|
|||
|
Interest expense
|
|
|
|
|
|||
|
Total expenses
|
|
|
|
|
|||
|
(=) Distributable Earnings
|
$
|
$
|
$
|
$
|
|||
|
(-) Realized Net Performance Revenues
|
|
|
|
|
|||
|
(-) Realized Principal Investment Income
|
(
|
|
|
|
|||
|
(+) Net Interest
|
|
|
|
|
|||
|
(=) Fee Related Earnings
|
$
|
$
|
$
|
$
|
|||
|
Nine Months Ended September 30, 2025
|
|||||||
|
Global
Private
Equity
|
Global
Credit
|
Carlyle
AlpInvest
|
Total
|
||||
|
(Dollars in millions)
|
|||||||
|
Segment Revenues
|
|||||||
|
Fund level fee revenues
|
|||||||
|
Fund management fees
|
$
|
$
|
$
|
$
|
|||
|
Portfolio advisory and transaction fees, net and other
|
|
|
|
|
|||
|
Fee related performance revenues
|
|
|
|
|
|||
|
Total fund level fee revenues
|
|
|
|
|
|||
|
Realized performance revenues
|
|
|
|
|
|||
|
Realized principal investment income
|
|
|
|
|
|||
|
Interest income
|
|
|
|
|
|||
|
Total revenues
|
|
|
|
|
|||
|
Segment Expenses
|
|||||||
|
Compensation and benefits
|
|||||||
|
Cash-based compensation and benefits
|
|
|
|
|
|||
|
Realized performance revenues related compensation
|
|
|
|
|
|||
|
Total compensation and benefits
|
|
|
|
|
|||
|
General, administrative, and other indirect expenses
(1)
|
|
|
|
|
|||
|
Depreciation and amortization expense
|
|
|
|
|
|||
|
Interest expense
|
|
|
|
|
|||
|
Total expenses
|
|
|
|
|
|||
|
(=) Distributable Earnings
|
$
|
$
|
$
|
$
|
|||
|
(-) Realized Net Performance Revenues
|
|
|
|
|
|||
|
(-) Realized Principal Investment Income
|
|
|
|
|
|||
|
(+) Net Interest
|
|
|
|
|
|||
|
(=) Fee Related Earnings
|
$
|
$
|
$
|
$
|
|||
|
Three Months Ended September 30, 2024
|
|||||||
|
Global
Private
Equity
|
Global
Credit
|
Carlyle
AlpInvest
|
Total
|
||||
|
(Dollars in millions)
|
|||||||
|
Segment Revenues
|
|||||||
|
Fund level fee revenues
|
|||||||
|
Fund management fees
|
$
|
$
|
$
|
$
|
|||
|
Portfolio advisory and transaction fees, net and other
|
|
|
|
|
|||
|
Fee related performance revenues
|
|
|
|
|
|||
|
Total fund level fee revenues
|
|
|
|
|
|||
|
Realized performance revenues
|
|
|
|
|
|||
|
Realized principal investment income (loss)
|
|
(
|
|
|
|||
|
Interest income
|
|
|
|
|
|||
|
Total revenues
|
|
|
|
|
|||
|
Segment Expenses
|
|||||||
|
Compensation and benefits
|
|||||||
|
Cash-based compensation and benefits
|
|
|
|
|
|||
|
Realized performance revenues related compensation
|
|
|
|
|
|||
|
Total compensation and benefits
|
|
|
|
|
|||
|
General, administrative, and other indirect expenses
(1)
|
|
|
|
|
|||
|
Depreciation and amortization expense
|
|
|
|
|
|||
|
Interest expense
|
|
|
|
|
|||
|
Total expenses
|
|
|
|
|
|||
|
(=) Distributable Earnings
|
$
|
$
|
$
|
$
|
|||
|
(-) Realized Net Performance Revenues
|
|
|
|
|
|||
|
(-) Realized Principal Investment Income (Loss)
|
|
(
|
|
|
|||
|
(+) Net Interest
|
|
|
|
|
|||
|
(=) Fee Related Earnings
|
$
|
$
|
$
|
$
|
|||
|
|
Nine Months Ended September 30, 2024
|
||||||
|
Global
Private
Equity
|
Global
Credit
|
Carlyle
AlpInvest
|
Total
|
||||
|
|
(Dollars in millions)
|
||||||
|
Segment Revenues
|
|||||||
|
Fund level fee revenues
|
|||||||
|
Fund management fees
|
$
|
$
|
$
|
$
|
|||
|
Portfolio advisory and transaction fees, net and other
|
|
|
|
|
|||
|
Fee related performance revenues
|
|
|
|
|
|||
|
Total fund level fee revenues
|
|
|
|
|
|||
|
Realized performance revenues
|
|
|
|
|
|||
|
Realized principal investment income
|
|
|
|
|
|||
|
Interest income
|
|
|
|
|
|||
|
Total revenues
|
|
|
|
|
|||
|
Segment Expenses
|
|||||||
|
Compensation and benefits
|
|||||||
|
Cash-based compensation and benefits
|
|
|
|
|
|||
|
Realized performance revenues related compensation
|
|
|
|
|
|||
|
Total compensation and benefits
|
|
|
|
|
|||
|
General, administrative, and other indirect expenses
(1)
|
|
|
|
|
|||
|
Depreciation and amortization expense
|
|
|
|
|
|||
|
Interest expense
|
|
|
|
|
|||
|
Total expenses
|
|
|
|
|
|||
|
(=) Distributable Earnings
|
$
|
$
|
$
|
$
|
|||
|
(-) Realized Net Performance Revenues
|
|
|
|
|
|||
|
(-) Realized Principal Investment Income
|
|
|
|
|
|||
|
(+) Net Interest
|
|
|
|
|
|||
|
(=) Fee Related Earnings
|
$
|
$
|
$
|
$
|
|||
|
|
Three Months Ended September 30, 2025
|
||||||||
|
|
Total
Reportable
Segments
|
Consolidated
Funds
|
Reconciling
Items
|
Carlyle
Consolidated
|
|||||
|
|
|||||||||
|
|
(Dollars in millions)
|
||||||||
|
Revenues
|
$
|
$
|
$
(
|
(a)
|
$
|
||||
|
Expenses
|
$
|
$
|
$
(
|
(b)
|
$
|
||||
|
Other income (loss)
|
$
|
$
|
$
|
(c)
|
$
|
||||
|
Distributable earnings
|
$
|
$
|
$
(
|
(d)
|
$
|
||||
|
|
Three Months Ended September 30, 2024
|
||||||||
|
|
Total
Reportable
Segments
|
Consolidated
Funds
|
Reconciling
Items
|
Carlyle
Consolidated
|
|||||
|
|
|||||||||
|
|
(Dollars in millions)
|
||||||||
|
Revenues
|
$
|
$
|
$
|
(a)
|
$
|
||||
|
Expenses
|
$
|
$
|
$
|
(b)
|
$
|
||||
|
Other income (loss)
|
$
|
$
|
$
|
(c)
|
$
|
||||
|
Distributable earnings
|
$
|
$
|
$
|
(d)
|
$
|
||||
|
|
Nine Months Ended September 30, 2025
|
||||||||
|
|
Total
Reportable
Segments
|
Consolidated
Funds
|
Reconciling
Items
|
Carlyle
Consolidated
|
|||||
|
|
|||||||||
|
|
(Dollars in millions)
|
||||||||
|
Revenues
|
$
|
$
|
$
(
|
(a)
|
$
|
||||
|
Expenses
|
$
|
$
|
$
|
(b)
|
$
|
||||
|
Other income (loss)
|
$
|
$
|
$
|
(c)
|
$
|
||||
|
Distributable earnings
|
$
|
$
|
$
(
|
(d)
|
$
|
||||
|
|
Nine Months Ended September 30, 2024
|
||||||||
|
|
Total
Reportable
Segments
|
Consolidated
Funds
|
Reconciling
Items
|
|
Carlyle
Consolidated
|
||||
|
|
|
||||||||
|
|
(Dollars in millions)
|
||||||||
|
Revenues
|
$
|
$
|
$
|
(a)
|
$
|
||||
|
Expenses
|
$
|
$
|
$
|
(b)
|
$
|
||||
|
Other income (loss)
|
$
|
$
(
|
$
|
(c)
|
$
(
|
||||
|
Distributable earnings
|
$
|
$
|
$
(
|
(d)
|
$
|
||||
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
||||||
|
|
2025
|
2024
|
2025
|
2024
|
|||
|
(Dollars in millions)
|
|||||||
|
Unrealized performance and fee related performance revenues
|
$
(
|
$
|
$
(
|
$
|
|||
|
Unrealized principal investment income (loss)
|
(
|
|
|
|
|||
|
Adjustments related to expenses associated with investments in NGP
Management and its affiliates
|
(
|
(
|
(
|
(
|
|||
|
Non-controlling interests and other adjustments to present certain costs on
a net basis
|
|
|
|
|
|||
|
Elimination of revenues of Consolidated Funds
|
(
|
(
|
(
|
(
|
|||
|
$
(
|
$
|
$
(
|
$
|
||||
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
||||||
|
2025
|
2024
|
2025
|
2024
|
||||
|
(Dollars in millions)
|
|||||||
|
Total Reportable Segments - Fund level fee revenues
|
$
|
$
|
$
|
$
|
|||
|
Adjustments
(1)
|
(
|
(
|
(
|
(
|
|||
|
Carlyle Consolidated - Fund management fees
|
$
|
$
|
$
|
$
|
|||
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
||||||
|
|
2025
|
2024
|
2025
|
2024
|
|||
|
(Dollars in millions)
|
|||||||
|
Unrealized performance and fee related performance revenue
compensation expense
|
$
(
|
$
|
$
(
|
$
|
|||
|
Equity-based compensation
|
|
|
|
|
|||
|
Acquisition or disposition-related charges and amortization of intangibles
and impairment
|
|
|
|
|
|||
|
Tax (expense) benefit associated with certain foreign performance
revenues related compensation
|
(
|
(
|
(
|
(
|
|||
|
Non-controlling interests and other adjustments to present certain costs on
a net basis
|
|
|
|
|
|||
|
Other adjustments
|
|
|
|
|
|||
|
Elimination of expenses of Consolidated Funds
|
(
|
|
(
|
(
|
|||
|
$
(
|
$
|
$
|
$
|
||||
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
||||||
|
|
2025
|
2024
|
2025
|
2024
|
|||
|
(Dollars in millions)
|
|||||||
|
Income (loss) before provision for income taxes
|
$
|
$
|
$
|
$
|
|||
|
Adjustments:
|
|||||||
|
Net unrealized performance and fee related performance revenues
|
|
(
|
|
(
|
|||
|
Unrealized principal investment (income) loss
|
|
(
|
(
|
(
|
|||
|
Equity-based compensation
(1)
|
|
|
|
|
|||
|
Acquisition or disposition-related charges, including amortization of intangibles
and impairment
|
|
|
|
|
|||
|
Tax (expense) benefit associated with certain foreign performance revenues
|
(
|
(
|
(
|
(
|
|||
|
Net income attributable to non-controlling interests in consolidated entities
|
(
|
(
|
(
|
(
|
|||
|
Other adjustments
(2)
|
|
|
|
|
|||
|
Distributable Earnings
|
$
|
$
|
$
|
$
|
|||
|
Realized performance revenues, net of related compensation
(3)
|
|
|
|
|
|||
|
Realized principal investment income
(3)
|
|
|
|
|
|||
|
Net interest
|
|
|
|
|
|||
|
Fee Related Earnings
|
$
|
$
|
$
|
$
|
|||
|
Three Months Ended September 30, 2025
|
|||||
|
Carlyle
Consolidated
|
Adjustments
(4)
|
Total
Reportable
Segments
|
|||
|
(Dollars in millions)
|
|||||
|
Performance revenues
|
$
(
|
$
|
$
|
||
|
Performance revenues related compensation expense
|
(
|
|
|
||
|
Net performance revenues
|
$
(
|
$
|
$
|
||
|
Principal investment income (loss)
|
$
|
$
(
|
$
|
||
|
Nine Months Ended September 30, 2025
|
|||||
|
Carlyle
Consolidated
|
Adjustments
(4)
|
Total
Reportable
Segments
|
|||
|
(Dollars in millions)
|
|||||
|
Performance revenues
|
$
|
$
|
$
|
||
|
Performance revenues related compensation expense
|
|
|
|
||
|
Net performance revenues
|
$
(
|
$
|
$
|
||
|
Principal investment income (loss)
|
$
|
$
|
$
|
||
|
Three Months Ended September 30, 2024
|
|||||
|
Carlyle
Consolidated
|
Adjustments
(4)
|
Total
Reportable
Segments
|
|||
|
(Dollars in millions)
|
|||||
|
Performance revenues
|
$
|
$
(
|
$
|
||
|
Performance revenues related compensation expense
|
|
(
|
|
||
|
Net performance revenues
|
$
|
$
(
|
$
|
||
|
Principal investment income (loss)
|
$
|
$
(
|
$
|
||
|
Nine Months Ended September 30, 2024
|
|||||
|
Carlyle
Consolidated
|
Adjustments
(4)
|
Total
Reportable
Segments
|
|||
|
(Dollars in millions)
|
|||||
|
Performance revenues
|
$
|
$
(
|
$
|
||
|
Performance revenues related compensation expense
|
|
(
|
|
||
|
Net performance revenues
|
$
|
$
(
|
$
|
||
|
Principal investment income (loss)
|
$
|
$
(
|
$
|
||
|
|
As of September 30, 2025
|
||||||
|
|
Consolidated
Operating
Entities
|
Consolidated
Funds
|
Eliminations
|
Consolidated
|
|||
|
|
(Dollars in millions)
|
||||||
|
Assets
|
|||||||
|
Cash and cash equivalents
|
$
|
$
|
$
|
$
|
|||
|
Cash and cash equivalents held at Consolidated Funds
|
|
|
|
|
|||
|
Investments, including accrued performance allocations of
$
|
|
|
(
|
|
|||
|
Investments of Consolidated Funds
|
|
|
|
|
|||
|
Due from affiliates and other receivables, net
|
|
|
(
|
|
|||
|
Due from affiliates and other receivables of Consolidated Funds, net
|
|
|
|
|
|||
|
Fixed assets, net
|
|
|
|
|
|||
|
Lease right-of-use assets, net
|
|
|
|
|
|||
|
Deposits and other
|
|
|
|
|
|||
|
Intangible assets, net
|
|
|
|
|
|||
|
Deferred tax assets
|
|
|
|
|
|||
|
Total assets
|
$
|
$
|
$
(
|
$
|
|||
|
Liabilities and equity
|
|||||||
|
Debt obligations
|
$
|
$
|
$
|
$
|
|||
|
Loans payable of Consolidated Funds
|
|
|
(
|
|
|||
|
Accounts payable, accrued expenses and other liabilities
|
|
|
|
|
|||
|
Accrued compensation and benefits
|
|
|
|
|
|||
|
Due to affiliates
|
|
|
|
|
|||
|
Deferred revenue
|
|
|
|
|
|||
|
Deferred tax liabilities
|
|
|
|
|
|||
|
Other liabilities of Consolidated Funds
|
|
|
(
|
|
|||
|
Lease liabilities
|
|
|
|
|
|||
|
Accrued giveback obligations
|
|
|
|
|
|||
|
Total liabilities
|
|
|
(
|
|
|||
|
Common stock
|
|
|
|
|
|||
|
Additional paid-in capital
|
|
|
(
|
|
|||
|
Retained earnings
|
|
|
|
|
|||
|
Accumulated other comprehensive loss
|
(
|
|
|
(
|
|||
|
Non-controlling interests in consolidated entities
|
|
|
|
|
|||
|
Total equity
|
|
|
(
|
|
|||
|
Total liabilities and equity
|
$
|
$
|
$
(
|
$
|
|||
|
As of December 31, 2024
|
|||||||
|
|
Consolidated
Operating
Entities
|
Consolidated
Funds
|
Eliminations
|
Consolidated
|
|||
|
|
(Dollars in millions)
|
||||||
|
Assets
|
|||||||
|
Cash and cash equivalents
|
$
|
$
|
$
|
$
|
|||
|
Cash and cash equivalents held at Consolidated Funds
|
|
|
|
|
|||
|
Investments, including accrued performance allocations of
$
|
|
|
(
|
|
|||
|
Investments of Consolidated Funds
|
|
|
|
|
|||
|
Due from affiliates and other receivables, net
|
|
|
(
|
|
|||
|
Due from affiliates and other receivables of Consolidated Funds, net
|
|
|
|
|
|||
|
Fixed assets, net
|
|
|
|
|
|||
|
Lease right-of-use assets, net
|
|
|
|
|
|||
|
Deposits and other
|
|
|
|
|
|||
|
Intangible assets, net
|
|
|
|
|
|||
|
Deferred tax assets
|
|
|
|
|
|||
|
Total assets
|
$
|
$
|
$
(
|
$
|
|||
|
Liabilities and equity
|
|||||||
|
Debt obligations
|
$
|
$
|
$
|
$
|
|||
|
Loans payable of Consolidated Funds
|
|
|
(
|
|
|||
|
Accounts payable, accrued expenses and other liabilities
|
|
|
|
|
|||
|
Accrued compensation and benefits
|
|
|
|
|
|||
|
Due to affiliates
|
|
|
|
|
|||
|
Deferred revenue
|
|
|
|
|
|||
|
Deferred tax liabilities
|
|
|
|
|
|||
|
Other liabilities of Consolidated Funds
|
|
|
(
|
|
|||
|
Lease liabilities
|
|
|
|
|
|||
|
Accrued giveback obligations
|
|
|
|
|
|||
|
Total liabilities
|
|
|
(
|
|
|||
|
Common stock
|
|
|
|
|
|||
|
Additional paid-in capital
|
|
|
(
|
|
|||
|
Retained earnings
|
|
|
|
|
|||
|
Accumulated other comprehensive loss
|
(
|
(
|
|
(
|
|||
|
Non-controlling interests in consolidated entities
|
|
|
|
|
|||
|
Total equity
|
|
|
(
|
|
|||
|
Total liabilities and equity
|
$
|
$
|
$
(
|
$
|
|||
|
|
Three Months Ended September 30, 2025
|
||||||
|
|
Consolidated
Operating
Entities
|
Consolidated
Funds
|
Eliminations
|
Consolidated
|
|||
|
|
(Dollars in millions)
|
||||||
|
Revenues
|
|||||||
|
Fund management fees
|
$
|
$
|
$
(
|
$
|
|||
|
Incentive fees
|
|
|
(
|
|
|||
|
Investment income
|
|||||||
|
Performance allocations
|
(
|
|
(
|
(
|
|||
|
Principal investment income
|
|
|
|
|
|||
|
Total investment income (loss)
|
(
|
|
|
(
|
|||
|
Interest and other income
|
|
|
(
|
|
|||
|
Interest and other income of Consolidated Funds
|
|
|
|
|
|||
|
Total revenues
|
|
|
(
|
|
|||
|
Expenses
|
|||||||
|
Compensation and benefits
|
|||||||
|
Cash-based compensation and benefits
|
|
|
|
|
|||
|
Equity-based compensation
|
|
|
|
|
|||
|
Performance allocations and incentive fee related compensation
|
(
|
|
|
(
|
|||
|
Total compensation and benefits
|
(
|
|
|
(
|
|||
|
General, administrative and other expenses
|
|
|
|
|
|||
|
Interest
|
|
|
|
|
|||
|
Interest and other expenses of Consolidated Funds
|
|
|
(
|
|
|||
|
Total expenses
|
|
|
(
|
|
|||
|
Other income
|
|||||||
|
Net investment income of Consolidated Funds
|
|
|
|
|
|||
|
Income (loss) before provision (benefit) for income taxes
|
(
|
|
|
|
|||
|
Provision (benefit) for income taxes
|
(
|
|
|
(
|
|||
|
Net income
|
|
|
|
|
|||
|
Net income attributable to non-controlling interests in consolidated
entities
|
|
|
|
|
|||
|
Net income attributable to The Carlyle Group Inc.
|
$
|
$
|
$
(
|
$
|
|||
|
|
Nine Months Ended September 30, 2025
|
||||||
|
|
Consolidated
Operating
Entities
|
Consolidated
Funds
|
Eliminations
|
Consolidated
|
|||
|
|
(Dollars in millions)
|
||||||
|
Revenues
|
|||||||
|
Fund management fees
|
$
|
$
|
$
(
|
$
|
|||
|
Incentive fees
|
|
|
(
|
|
|||
|
Investment income
|
|||||||
|
Performance allocations
|
|
|
(
|
|
|||
|
Principal investment income
|
|
|
|
|
|||
|
Total investment income
|
|
|
(
|
|
|||
|
Interest and other income
|
|
|
(
|
|
|||
|
Interest and other income of Consolidated Funds
|
|
|
|
|
|||
|
Total revenues
|
|
|
(
|
|
|||
|
Expenses
|
|||||||
|
Compensation and benefits
|
|||||||
|
Cash-based compensation and benefits
|
|
|
|
|
|||
|
Equity-based compensation
|
|
|
|
|
|||
|
Performance allocations and incentive fee related compensation
|
|
|
|
|
|||
|
Total compensation and benefits
|
|
|
|
|
|||
|
General, administrative and other expenses
|
|
|
|
|
|||
|
Interest
|
|
|
|
|
|||
|
Interest and other expenses of Consolidated Funds
|
|
|
(
|
|
|||
|
Other non-operating income
|
(
|
|
|
(
|
|||
|
Total expenses
|
|
|
(
|
|
|||
|
Other income
|
|||||||
|
Net investment
income
of Consolidated Funds
|
|
|
|
|
|||
|
Income before provision for income taxes
|
|
|
(
|
|
|||
|
Provision for income taxes
|
|
|
|
|
|||
|
Net income
|
|
|
(
|
|
|||
|
Net income attributable to non-controlling interests in consolidated
entities
|
|
|
|
|
|||
|
Net income attributable to The Carlyle Group Inc.
|
$
|
$
|
$
(
|
$
|
|||
|
Three Months Ended September 30, 2024
|
|||||||
|
Consolidated
Operating
Entities
|
Consolidated
Funds
|
Eliminations
|
Consolidated
|
||||
|
(Dollars in millions)
|
|||||||
|
Revenues
|
|||||||
|
Fund management fees
|
$
|
$
|
$
(
|
$
|
|||
|
Incentive fees
|
|
|
(
|
|
|||
|
Investment income
|
|||||||
|
Performance allocations
|
|
|
(
|
|
|||
|
Principal investment income
|
|
|
(
|
|
|||
|
Total investment income
|
|
|
(
|
|
|||
|
Interest and other income
|
|
|
(
|
|
|||
|
Interest and other income of Consolidated Funds
|
|
|
|
|
|||
|
Total revenues
|
|
|
(
|
|
|||
|
Expenses
|
|||||||
|
Compensation and benefits
|
|||||||
|
Cash-based compensation and benefits
|
|
|
|
|
|||
|
Equity-based compensation
|
|
|
|
|
|||
|
Performance allocations and incentive fee related compensation
|
|
|
|
|
|||
|
Total compensation and benefits
|
|
|
|
|
|||
|
General, administrative and other expenses
|
|
|
|
|
|||
|
Interest
|
|
|
|
|
|||
|
Interest and other expenses of Consolidated Funds
|
|
|
|
|
|||
|
Other non-operating income
|
(
|
|
|
(
|
|||
|
Total expenses
|
|
|
|
|
|||
|
Other income
|
|||||||
|
Net investment income of Consolidated Funds
|
|
|
|
|
|||
|
Income before provision for income taxes
|
|
|
(
|
|
|||
|
Provision for income taxes
|
|
|
|
|
|||
|
Net income
|
|
|
(
|
|
|||
|
Net income attributable to non-controlling interests in consolidated
entities
|
|
|
|
|
|||
|
Net income attributable to The Carlyle Group Inc.
|
$
|
$
|
$
(
|
$
|
|||
|
Nine Months Ended September 30, 2024
|
|||||||
|
|
Consolidated
Operating
Entities
|
Consolidated
Funds
|
Eliminations
|
Consolidated
|
|||
|
|
(Dollars in millions)
|
||||||
|
Revenues
|
|||||||
|
Fund management fees
|
$
|
$
|
$
(
|
$
|
|||
|
Incentive fees
|
|
|
(
|
|
|||
|
Investment income
|
|||||||
|
Performance allocations
|
|
|
(
|
|
|||
|
Principal investment income
|
|
|
(
|
|
|||
|
Total investment income
|
|
|
(
|
|
|||
|
Interest and other income
|
|
|
(
|
|
|||
|
Interest and other income of Consolidated Funds
|
|
|
|
|
|||
|
Total revenues
|
|
|
(
|
|
|||
|
Expenses
|
|||||||
|
Compensation and benefits
|
|||||||
|
Cash-based compensation and benefits
|
|
|
|
|
|||
|
Equity-based compensation
|
|
|
|
|
|||
|
Performance allocations and incentive fee related compensation
|
|
|
|
|
|||
|
Total compensation and benefits
|
|
|
|
|
|||
|
General, administrative and other expenses
|
|
|
|
|
|||
|
Interest
|
|
|
|
|
|||
|
Interest and other expenses of Consolidated Funds
|
|
|
(
|
|
|||
|
Other non-operating income
|
(
|
|
|
(
|
|||
|
Total expenses
|
|
|
(
|
|
|||
|
Other income (loss)
|
|||||||
|
Net investment
loss
of Consolidated Funds
|
|
(
|
|
(
|
|||
|
Income before provision for income taxes
|
|
|
(
|
|
|||
|
Provision for income taxes
|
|
|
|
|
|||
|
Net income
|
|
|
(
|
|
|||
|
Net income attributable to non-controlling interests in consolidated
entities
|
|
|
|
|
|||
|
Net income attributable to The Carlyle Group Inc.
|
$
|
$
|
$
(
|
$
|
|||
|
|
Nine Months Ended September 30,
|
||
|
|
2025
|
2024
|
|
|
|
(Dollars in millions)
|
||
|
Cash flows from operating activities
|
|||
|
Net income
|
$
|
$
|
|
|
Adjustments to reconcile net income to net cash flows from operating activities:
|
|||
|
Depreciation and amortization
|
|
|
|
|
Equity-based compensation
|
|
|
|
|
Non-cash performance allocations and incentive fees
|
|
(
|
|
|
Non-cash principal investment (income) loss
|
(
|
(
|
|
|
Other non-cash amounts
|
|
|
|
|
Purchases of investments
|
(
|
(
|
|
|
Proceeds from the sale of investments
|
|
|
|
|
Payments of contingent consideration
|
(
|
(
|
|
|
Change in deferred taxes, net
|
(
|
|
|
|
Change in due from affiliates and other receivables
|
(
|
(
|
|
|
Change in deposits and other
|
(
|
(
|
|
|
Change in accounts payable, accrued expenses and other liabilities
|
|
|
|
|
Change in accrued compensation and benefits
|
(
|
(
|
|
|
Change in due to affiliates
|
|
(
|
|
|
Change in lease right-of-use assets and lease liabilities
|
(
|
(
|
|
|
Change in deferred revenue
|
|
|
|
|
Net cash provided by operating activities
|
|
|
|
|
Cash flows from investing activities
|
|||
|
Purchases of corporate treasury investments
|
|
(
|
|
|
Proceeds from corporate treasury investments
|
|
|
|
|
Purchases of fixed assets, net
|
(
|
(
|
|
|
Net cash used in investing activities
|
(
|
(
|
|
|
Cash flows from financing activities
|
|||
|
Borrowings under credit facilities
|
|
|
|
|
Repayments under credit facilities
|
|
(
|
|
|
Issuance of
|
|
|
|
|
Payments on CLO borrowings
|
(
|
(
|
|
|
Proceeds from CLO borrowings, net of financing costs
|
|
|
|
|
Dividends to common stockholders
|
(
|
(
|
|
|
Payment of deferred consideration for Carlyle Holdings units
|
|
(
|
|
|
Contributions from non-controlling interest holders
|
|
|
|
|
Distributions to non-controlling interest holders
|
(
|
(
|
|
|
Common shares repurchased and net share settlement of equity-based awards
|
(
|
(
|
|
|
Change in due to/from affiliates financing activities
|
|
|
|
|
Net cash used in financing activities
|
|
(
|
|
|
Effect of foreign exchange rate changes
|
|
|
|
|
Increase (decrease) in cash, cash equivalents and restricted cash
|
|
(
|
|
|
Cash, cash equivalents and restricted cash, beginning of period
|
|
|
|
|
Cash, cash equivalents and restricted cash, end of period
|
$
|
$
|
|
|
Reconciliation of cash, cash equivalents and restricted cash, end of period:
|
|||
|
Cash and cash equivalents
|
$
|
$
|
|
|
Restricted cash
|
|
|
|
|
Total cash, cash equivalents and restricted cash, end of period
|
$
|
$
|
|
|
Cash and cash equivalents held at Consolidated Funds
|
$
|
$
|
|
|
Global Private Equity
|
$
163.4
|
Global Credit
|
$
208.5
|
|
|
Corporate Private Equity
|
$
104.8
|
Insurance Solutions
4
|
$
87.0
|
|
|
U.S. Buyout (CP)
|
51.8
|
Liquid Credit
|
$
49.4
|
|
|
Asia Buyout (CAP)
|
11.6
|
U.S. CLOs
|
34.4
|
|
|
Europe Buyout (CEP)
|
10.4
|
Europe CLOs
|
10.4
|
|
|
Carlyle Global Partners (CGP)
|
6.8
|
CLO Investment Products
|
2.6
|
|
|
Europe Technology (CETP)
|
6.1
|
Revolving Credit
|
2.0
|
|
|
Japan Buyout (CJP)
|
6.1
|
Private Credit
|
$
72.1
|
|
|
U.S. Growth (CP Growth / CEOF)
|
3.2
|
Opportunistic Credit (CCOF / CSP)
|
20.3
|
|
|
Life Sciences (ABV / ACCD)
|
2.2
|
Direct Lending
5
|
12.9
|
|
|
Asia Growth (CAP Growth / CAGP)
|
1.2
|
Aviation Finance (SASOF / CALF)
|
12.3
|
|
|
Other
1
|
5.5
|
Cross-Platform Credit (incl. CTAC)
|
9.8
|
|
|
Real Estate
|
$
36.1
|
Asset-Backed Finance
|
9.7
|
|
|
U.S. Real Estate (CRP)
|
25.3
|
Infrastructure Credit (CICF)
|
6.7
|
|
|
Core Plus Real Estate (CPI)
|
8.2
|
Other
6
|
0.5
|
|
|
International Real Estate (CER)
|
2.5
|
|||
|
Infrastructure & Natural Resources
|
$
22.5
|
Carlyle AlpInvest
|
$
102.1
|
|
|
NGP Energy
2
|
10.7
|
Secondaries and Portfolio Finance (ASF / ASPF)
|
$
45.5
|
|
|
Infrastructure and Renewable Energy
3
|
6.4
|
Co-Investments (ACF)
|
$
25.2
|
|
|
International Energy (CIEP)
|
5.4
|
Primary Investments & Other
7
|
$
31.5
|
|
|
|
As of September 30,
|
||
|
|
2025
|
2024
|
|
|
Consolidated Results
|
(Dollars in millions)
|
||
|
Components of Fee-earning AUM
|
|||
|
Fee-earning AUM based on capital commitments
|
$
71,995
|
$
71,247
|
|
|
Fee-earning AUM based on invested capital
|
79,310
|
73,090
|
|
|
Fee-earning AUM based on collateral balances, at par
|
43,929
|
46,454
|
|
|
Fee-earning AUM based on net asset value
|
28,344
|
21,992
|
|
|
Fee-earning AUM based on fair value and other
|
108,376
|
100,824
|
|
|
Balance, End of Period
(1)
|
$
331,954
|
$
313,607
|
|
|
|
Three Months Ended September 30,
|
Nine Months Ended September 30,
|
|||||
|
|
2025
|
2024
|
2025
|
2024
|
|||
|
Consolidated Results
|
(Dollars in millions)
|
||||||
|
Fee-earning AUM Rollforward
|
|||||||
|
Balance, Beginning of Period
|
$
324,701
|
$
307,345
|
$
304,358
|
$
307,418
|
|||
|
Inflows
(1)
|
14,092
|
5,359
|
43,996
|
21,259
|
|||
|
Outflows (including realizations)
(2)
|
(7,563)
|
(5,129)
|
(23,974)
|
(18,582)
|
|||
|
Market Activity & Other
(3)
|
848
|
4,184
|
2,487
|
3,235
|
|||
|
Foreign Exchange
(4)
|
(124)
|
1,848
|
5,087
|
277
|
|||
|
Balance, End of Period
|
$
331,954
|
$
313,607
|
$
331,954
|
$
313,607
|
|||
|
|
Three Months Ended
September 30, 2025
|
Nine Months Ended
September 30, 2025
|
|
|
Consolidated Results
|
(Dollars in millions)
|
||
|
Total AUM Rollforward
|
|||
|
Balance, Beginning of Period
|
$
464,602
|
$
441,020
|
|
|
Inflows
(1)
|
16,864
|
44,476
|
|
|
Outflows (including realizations)
(2)
|
(11,731)
|
(31,746)
|
|
|
Market Activity & Other
(3)
|
4,528
|
12,396
|
|
|
Foreign Exchange
(4)
|
(204)
|
7,913
|
|
|
Balance, End of Period
|
$
474,059
|
$
474,059
|
|
|
|
Three Months Ended
September 30,
|
Change
|
Nine Months Ended
September 30,
|
Change
|
|||||||||||
|
|
2025
|
2024
|
$
|
%
|
2025
|
2024
|
$
|
%
|
|||||||
|
|
(Dollars in millions)
|
||||||||||||||
|
Revenues
|
|||||||||||||||
|
Fund management fees
|
$
583.3
|
$
532.7
|
$
50.6
|
9
%
|
$
1,789.8
|
$
1,590.7
|
$
199.1
|
13
%
|
|||||||
|
Incentive fees
|
51.4
|
38.7
|
12.7
|
33
%
|
135.1
|
96.2
|
38.9
|
40
%
|
|||||||
|
Investment income (loss)
|
|||||||||||||||
|
Performance allocations
|
(606.7)
|
1,785.5
|
(2,392.2)
|
NM
|
255.0
|
1,826.7
|
(1,571.7)
|
(86)
%
|
|||||||
|
Principal investment income
|
87.7
|
46.0
|
41.7
|
91
%
|
79.8
|
207.2
|
(127.4)
|
(61)
%
|
|||||||
|
Total investment income
(loss)
|
(519.0)
|
1,831.5
|
(2,350.5)
|
NM
|
334.8
|
2,033.9
|
(1,699.1)
|
(84)
%
|
|||||||
|
Interest and other income
|
53.6
|
52.2
|
1.4
|
3
%
|
159.2
|
161.9
|
(2.7)
|
(2)
%
|
|||||||
|
Interest and other income of
Consolidated Funds
|
163.4
|
180.1
|
(16.7)
|
(9)
%
|
459.8
|
510.6
|
(50.8)
|
(10)
%
|
|||||||
|
Total revenues
|
332.7
|
2,635.2
|
(2,302.5)
|
(87)
%
|
2,878.7
|
4,393.3
|
(1,514.6)
|
(34)
%
|
|||||||
|
Expenses
|
|||||||||||||||
|
Compensation and benefits
|
|||||||||||||||
|
Cash-based compensation and
benefits
|
216.2
|
207.5
|
8.7
|
4
%
|
673.0
|
635.7
|
37.3
|
6
%
|
|||||||
|
Equity-based compensation
|
90.7
|
121.6
|
(30.9)
|
(25)
%
|
287.1
|
355.1
|
(68.0)
|
(19)
%
|
|||||||
|
Performance allocations and
incentive fee related
compensation
|
(324.6)
|
1,151.0
|
(1,475.6)
|
NM
|
290.4
|
1,222.4
|
(932.0)
|
(76)
%
|
|||||||
|
Total compensation and
benefits
|
(17.7)
|
1,480.1
|
(1,497.8)
|
NM
|
1,250.5
|
2,213.2
|
(962.7)
|
(43)
%
|
|||||||
|
General, administrative and other
expenses
|
180.7
|
176.6
|
4.1
|
2
%
|
559.8
|
512.2
|
47.6
|
9
%
|
|||||||
|
Interest
|
29.8
|
30.3
|
(0.5)
|
(2)
%
|
85.6
|
91.5
|
(5.9)
|
(6)
%
|
|||||||
|
Interest and other expenses of
Consolidated Funds
|
177.3
|
162.0
|
15.3
|
9
%
|
461.6
|
438.7
|
22.9
|
5
%
|
|||||||
|
Other non-operating income
|
—
|
(0.1)
|
0.1
|
(100)
%
|
(0.1)
|
(0.2)
|
0.1
|
(50)
%
|
|||||||
|
Total expenses
|
370.1
|
1,848.9
|
(1,478.8)
|
(80)
%
|
2,357.4
|
3,255.4
|
(898.0)
|
(28)
%
|
|||||||
|
Other income (loss)
|
|||||||||||||||
|
Net investment income (loss) of
Consolidated Funds
|
123.2
|
2.5
|
120.7
|
NM
|
176.1
|
(9.6)
|
185.7
|
NM
|
|||||||
|
Income before provision for income
taxes
|
85.8
|
788.8
|
(703.0)
|
(89)
%
|
697.4
|
1,128.3
|
(430.9)
|
(38)
%
|
|||||||
|
Provision (benefit) for income taxes
|
(26.7)
|
173.1
|
(199.8)
|
NM
|
98.2
|
264.5
|
(166.3)
|
(63)
%
|
|||||||
|
Net income
|
112.5
|
615.7
|
(503.2)
|
(82)
%
|
599.2
|
863.8
|
(264.6)
|
(31)
%
|
|||||||
|
Net income attributable to non-
controlling interests in consolidated
entities
|
111.6
|
20.0
|
91.6
|
NM
|
148.6
|
54.3
|
94.3
|
174
%
|
|||||||
|
Net income attributable to The Carlyle
Group Inc. Common Stockholders
|
$
0.9
|
$
595.7
|
$
(594.8)
|
(100)
%
|
$
450.6
|
$
809.5
|
$
(358.9)
|
(44)
%
|
|||||||
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
||
|
2025 v. 2024
|
|||
|
(Dollars in millions)
|
|||
|
Higher management fees from the commencement of the investment period for
certain newly raised funds which charge fees based on commitments and the
impact of incremental fundraising in funds which activated fees in a prior period
|
$
67.7
|
$
183.3
|
|
|
Lower management fees resulting from the change in basis from commitments to
invested capital and step-downs in rate for certain funds, and the impact of net
investment activity in funds whose management fees are based on invested capital,
including the impact of changes in the base under the strategic advisory services
agreement with Fortitude
|
(33.2)
|
(107.4)
|
|
|
Increase in catch-up management fees from subsequent closes of funds that are in
the fundraising period
|
24.0
|
50.0
|
|
|
(Lower) higher transaction and portfolio advisory fees
|
(4.0)
|
68.5
|
|
|
All other changes
(1)
|
(3.9)
|
4.7
|
|
|
Total
increase
in Fund management fees
(2)
|
$
50.6
|
$
199.1
|
|
|
Three Months Ended
September 30,
|
Change
|
Nine Months Ended
September 30,
|
Change
|
||||||||||||
|
2025
|
2024
|
$
|
%
|
2025
|
2024
|
$
|
%
|
||||||||
|
(Dollars in millions)
|
|||||||||||||||
|
Performance allocations
|
$
(606.7)
|
$
1,785.5
|
$
(2,392.2)
|
NM
|
$
255.0
|
$
1,826.7
|
$
(1,571.7)
|
(86)
%
|
|||||||
|
Principal investment income
:
|
|||||||||||||||
|
Investment income (loss) from
NGP, which includes
performance allocations
|
29.8
|
34.7
|
(4.9)
|
(14)
%
|
(42.6)
|
85.2
|
(127.8)
|
NM
|
|||||||
|
Investment income (loss) from
our carry funds:
|
|||||||||||||||
|
Global Private Equity
|
9.1
|
23.1
|
(14.0)
|
(61)
%
|
28.5
|
36.9
|
(8.4)
|
(23)
%
|
|||||||
|
Global Credit
|
8.7
|
3.9
|
4.8
|
123
%
|
8.6
|
12.6
|
(4.0)
|
(32)
%
|
|||||||
|
Carlyle AlpInvest
|
16.3
|
15.1
|
1.2
|
8
%
|
42.8
|
21.9
|
20.9
|
95
%
|
|||||||
|
Investment income (loss) from
our CLOs
|
2.1
|
(7.5)
|
9.6
|
NM
|
(5.4)
|
21.5
|
(26.9)
|
NM
|
|||||||
|
Investment income from Carlyle
FRL
|
0.3
|
21.2
|
(20.9)
|
(99)
%
|
15.7
|
30.8
|
(15.1)
|
(49)
%
|
|||||||
|
Investment income (loss) from
our other Global Credit
products
|
1.4
|
(42.5)
|
43.9
|
NM
|
6.1
|
(13.6)
|
19.7
|
NM
|
|||||||
|
Investment income on foreign
currency hedges
|
0.4
|
0.3
|
0.1
|
33
%
|
2.1
|
5.2
|
(3.1)
|
(60)
%
|
|||||||
|
All other investment income
(loss)
|
19.6
|
(2.3)
|
21.9
|
NM
|
24.0
|
6.7
|
17.3
|
258
%
|
|||||||
|
Total
Principal investment income
|
87.7
|
46.0
|
41.7
|
91
%
|
79.8
|
207.2
|
(127.4)
|
(61)
%
|
|||||||
|
Total
Investment income (loss)
|
$
(519.0)
|
$
1,831.5
|
$
(2,350.5)
|
NM
|
$
334.8
|
$
2,033.9
|
$
(1,699.1)
|
(84)
%
|
|||||||
|
Three Months Ended
September 30,
|
Change
|
Nine Months Ended
September 30,
|
Change
|
||||||||||||
|
2025
|
2024
|
$
|
%
|
2025
|
2024
|
$
|
%
|
||||||||
|
(Dollars in millions)
|
|||||||||||||||
|
Global Private Equity
|
$
(781.4)
|
$
1,625.8
|
$
(2,407.2)
|
(148)
%
|
$
(219.5)
|
$
1,447.3
|
$
(1,666.8)
|
(115)
%
|
|||||||
|
Global Credit
|
93.3
|
58.7
|
34.6
|
59
%
|
223.1
|
170.0
|
53.1
|
31
%
|
|||||||
|
Carlyle AlpInvest
|
81.4
|
101.0
|
(19.6)
|
(19)
%
|
251.4
|
209.4
|
42.0
|
20
%
|
|||||||
|
Total performance allocations
|
$
(606.7)
|
$
1,785.5
|
$
(2,392.2)
|
NM
|
$
255.0
|
$
1,826.7
|
$
(1,571.7)
|
(86)
%
|
|||||||
|
|
Three Months Ended
September 30,
|
Change
|
Nine Months Ended
September 30,
|
Change
|
|||||||||||
|
|
2025
|
2024
|
$
|
%
|
2025
|
2024
|
$
|
%
|
|||||||
|
|
(Dollars in millions)
|
||||||||||||||
|
Realized gains (losses)
|
$
58.5
|
$
(4.5)
|
$
63.0
|
NM
|
$
33.6
|
$
(49.1)
|
$
82.7
|
NM
|
|||||||
|
Net change in unrealized gains (losses)
|
30.0
|
(20.4)
|
50.4
|
NM
|
66.5
|
107.2
|
(40.7)
|
(38)
%
|
|||||||
|
Total gains (losses)
|
88.5
|
(24.9)
|
113.4
|
NM
|
100.1
|
58.1
|
42.0
|
72
%
|
|||||||
|
Gains (losses) from liabilities of CLOs
|
34.7
|
27.4
|
7.3
|
27
%
|
76.0
|
(67.7)
|
143.7
|
NM
|
|||||||
|
Total net investment income (loss) of
Consolidated Funds
|
$
123.2
|
$
2.5
|
$
120.7
|
NM
|
$
176.1
|
$
(9.6)
|
$
185.7
|
NM
|
|||||||
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
||||||
|
2025
|
2024
|
2025
|
2024
|
||||
|
(Dollars in millions)
|
|||||||
|
Total Segment Revenues
|
$
782.5
|
$
895.0
|
$
2,809.7
|
$
2,706.9
|
|||
|
Total Segment Expenses
|
414.1
|
527.9
|
1,554.9
|
1,565.3
|
|||
|
(=) Distributable Earnings
|
$
368.4
|
$
367.1
|
$
1,254.8
|
$
1,141.6
|
|||
|
(-) Realized Net Performance Revenues
|
19.1
|
90.6
|
234.2
|
288.3
|
|||
|
(-) Realized Principal Investment Income
|
49.5
|
9.1
|
113.0
|
69.4
|
|||
|
(+) Net Interest
|
12.1
|
10.5
|
38.2
|
33.3
|
|||
|
(=) Fee Related Earnings
|
$
311.9
|
$
277.9
|
$
945.8
|
$
817.2
|
|||
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
||||||
|
2025
|
2024
|
2025
|
2024
|
||||
|
(Dollars in millions)
|
|||||||
|
Segment Revenues
|
|||||||
|
Fund level fee revenues
|
|||||||
|
Fund management fees
|
$
573.9
|
$
526.5
|
$
1,689.0
|
$
1,567.6
|
|||
|
Portfolio advisory and transaction fees, net and other
|
32.3
|
27.4
|
158.1
|
83.0
|
|||
|
Fee related performance revenues
|
47.5
|
36.3
|
125.7
|
98.5
|
|||
|
Total fund level fee revenues
|
653.7
|
590.2
|
1,972.8
|
1,749.1
|
|||
|
Realized performance revenues
|
61.7
|
275.9
|
676.6
|
830.2
|
|||
|
Realized principal investment income
|
49.5
|
9.1
|
113.0
|
69.4
|
|||
|
Interest income
|
17.6
|
19.8
|
47.3
|
58.2
|
|||
|
Total Segment Revenues
|
$
782.5
|
$
895.0
|
$
2,809.7
|
$
2,706.9
|
|||
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
||||||
|
2025
|
2024
|
2025
|
2024
|
||||
|
(Dollars in millions)
|
|||||||
|
Segment Expenses
|
|||||||
|
Compensation and benefits
|
|||||||
|
Cash-based compensation and benefits
|
$
220.5
|
$
207.6
|
$
678.3
|
$
627.2
|
|||
|
Realized performance revenue related compensation
|
42.6
|
185.3
|
442.4
|
541.9
|
|||
|
Total compensation and benefits
|
263.1
|
392.9
|
1,120.7
|
1,169.1
|
|||
|
General, administrative, and other indirect expenses
|
107.3
|
92.9
|
309.2
|
270.5
|
|||
|
Depreciation and amortization expense
|
14.0
|
11.8
|
39.5
|
34.2
|
|||
|
Interest expense
|
29.7
|
30.3
|
85.5
|
91.5
|
|||
|
Total Segment Expenses
|
$
414.1
|
$
527.9
|
$
1,554.9
|
$
1,565.3
|
|||
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
||||||
|
|
2025
|
2024
|
2025
|
2024
|
|||
|
|
(Dollars in millions)
|
||||||
|
Income (loss) before provision for income taxes
|
$
85.8
|
$
788.8
|
$
697.4
|
$
1,128.3
|
|||
|
Adjustments:
|
|||||||
|
Net unrealized performance and fee related performance revenues
|
244.6
|
(564.4)
|
210.3
|
(386.4)
|
|||
|
Unrealized principal investment (income) loss
|
7.4
|
(1.8)
|
(35.1)
|
(54.3)
|
|||
|
Equity-based compensation
(1)
|
88.2
|
122.0
|
289.3
|
360.4
|
|||
|
Acquisition or disposition-related charges, including amortization of
intangibles and impairment
|
46.2
|
37.4
|
216.7
|
103.5
|
|||
|
Tax (expense) benefit associated with certain foreign performance revenues
|
(0.4)
|
(0.2)
|
(0.5)
|
(1.4)
|
|||
|
Net (income) loss attributable to non-controlling interests in consolidated
entities
|
(111.6)
|
(20.0)
|
(148.6)
|
(54.3)
|
|||
|
Other adjustments
(2)
|
8.2
|
5.3
|
25.3
|
45.8
|
|||
|
(=) Distributable Earnings
|
$
368.4
|
$
367.1
|
$
1,254.8
|
$
1,141.6
|
|||
|
(-) Realized net performance revenues, net of related compensation
(3)
|
19.1
|
90.6
|
234.2
|
288.3
|
|||
|
(-) Realized principal investment income
(3)
|
49.5
|
9.1
|
113.0
|
69.4
|
|||
|
(+) Net interest
|
12.1
|
10.5
|
38.2
|
33.3
|
|||
|
(=) Fee Related Earnings
|
$
311.9
|
$
277.9
|
$
945.8
|
$
817.2
|
|||
|
|
Three Months Ended September 30, 2025
|
||||
|
|
Carlyle
Consolidated
|
Adjustments
(4)
|
Total
Reportable
Segments
|
||
|
|
(Dollars in millions)
|
||||
|
Performance revenues
|
$
(606.7)
|
$
668.4
|
$
61.7
|
||
|
Performance revenues related compensation expense
|
(324.6)
|
367.2
|
42.6
|
||
|
Net performance revenues
|
$
(282.1)
|
$
301.2
|
$
19.1
|
||
|
Principal investment income (loss)
|
$
87.7
|
$
(38.2)
|
$
49.5
|
||
|
Nine Months Ended September 30, 2025
|
|||||
|
Carlyle
Consolidated
|
Adjustments
(4)
|
Total
Reportable
Segments
|
|||
|
(Dollars in millions)
|
|||||
|
Performance revenues
|
$
255.0
|
$
421.6
|
$
676.6
|
||
|
Performance revenues related compensation expense
|
290.4
|
152.0
|
442.4
|
||
|
Net performance revenues
|
$
(35.4)
|
$
269.6
|
$
234.2
|
||
|
Principal investment income (loss)
|
$
79.8
|
$
33.2
|
$
113.0
|
||
|
|
Three Months Ended September 30, 2024
|
||||
|
|
Carlyle
Consolidated
|
Adjustments
(4)
|
Total
Reportable
Segments
|
||
|
|
(Dollars in millions)
|
||||
|
Performance revenues
|
$
1,785.5
|
$
(1,509.6)
|
$
275.9
|
||
|
Performance revenues related compensation expense
|
1,151.0
|
(965.7)
|
185.3
|
||
|
Net performance revenues
|
$
634.5
|
$
(543.9)
|
$
90.6
|
||
|
Principal investment income (loss)
|
$
46.0
|
$
(36.9)
|
$
9.1
|
||
|
Nine Months Ended September 30, 2024
|
|||||
|
Carlyle
Consolidated
|
Adjustments
(4)
|
Total
Reportable
Segments
|
|||
|
(Dollars in millions)
|
|||||
|
Performance revenues
|
$
1,826.7
|
$
(996.5)
|
$
830.2
|
||
|
Performance revenues related compensation expense
|
1,222.4
|
(680.5)
|
541.9
|
||
|
Net performance revenues
|
$
604.3
|
$
(316.0)
|
$
288.3
|
||
|
Principal investment income (loss)
|
$
207.2
|
$
(137.8)
|
$
69.4
|
||
|
|
Three Months Ended September 30,
|
Nine Months Ended September 30,
|
|||||
|
|
2025
|
2024
|
2025
|
2024
|
|||
|
|
(Dollars in millions)
|
||||||
|
Global Private Equity
|
$
146.8
|
$
235.5
|
$
644.3
|
$
747.7
|
|||
|
Global Credit
|
126.4
|
80.5
|
357.8
|
262.4
|
|||
|
Carlyle AlpInvest
|
95.2
|
51.1
|
252.7
|
131.5
|
|||
|
Distributable Earnings
|
$
368.4
|
$
367.1
|
$
1,254.8
|
$
1,141.6
|
|||
|
|
Three Months Ended
September 30,
|
Change
|
Nine Months Ended
September 30,
|
Change
|
|||||||||||
|
|
2025
|
2024
|
$
|
%
|
2025
|
2024
|
$
|
%
|
|||||||
|
|
(Dollars in millions)
|
||||||||||||||
|
Segment Revenues
|
|||||||||||||||
|
Fund level fee revenues
|
|||||||||||||||
|
Fund management fees
|
$
295.0
|
$
298.6
|
$
(3.6)
|
(1)
%
|
$
880.4
|
$
908.4
|
$
(28.0)
|
(3)
%
|
|||||||
|
Portfolio advisory and
transaction fees, net and other
|
6.5
|
5.9
|
0.6
|
10
%
|
27.9
|
16.8
|
11.1
|
66
%
|
|||||||
|
Fee related performance
revenues
|
—
|
—
|
—
|
NM
|
—
|
6.9
|
(6.9)
|
(100)
%
|
|||||||
|
Total fund level fee revenues
|
301.5
|
304.5
|
(3.0)
|
(1)
%
|
908.3
|
932.1
|
(23.8)
|
(3)
%
|
|||||||
|
Realized performance revenues
|
38.0
|
225.2
|
(187.2)
|
(83)
%
|
599.8
|
728.7
|
(128.9)
|
(18)
%
|
|||||||
|
Realized principal investment
income (loss)
|
(0.4)
|
10.0
|
(10.4)
|
NM
|
27.1
|
35.7
|
(8.6)
|
(24)
%
|
|||||||
|
Interest income
|
7.4
|
7.7
|
(0.3)
|
(4)
%
|
18.9
|
21.8
|
(2.9)
|
(13)
%
|
|||||||
|
Total revenues
|
346.5
|
547.4
|
(200.9)
|
(37)
%
|
1,554.1
|
1,718.3
|
(164.2)
|
(10)
%
|
|||||||
|
Segment Expenses
|
|||||||||||||||
|
Compensation and benefits
|
|||||||||||||||
|
Cash-based compensation and
benefits
|
97.4
|
101.1
|
(3.7)
|
(4)
%
|
306.5
|
314.3
|
(7.8)
|
(2)
%
|
|||||||
|
Realized performance revenues
related compensation
|
24.2
|
141.5
|
(117.3)
|
(83)
%
|
385.5
|
457.2
|
(71.7)
|
(16)
%
|
|||||||
|
Total compensation and
benefits
|
121.6
|
242.6
|
(121.0)
|
(50)
%
|
692.0
|
771.5
|
(79.5)
|
(10)
%
|
|||||||
|
General, administrative, and other
indirect expenses
(1)
|
56.2
|
48.5
|
7.7
|
16
%
|
155.2
|
137.3
|
17.9
|
13
%
|
|||||||
|
Depreciation and amortization
expense
|
7.6
|
6.7
|
0.9
|
13
%
|
21.5
|
19.6
|
1.9
|
10
%
|
|||||||
|
Interest expense
|
14.3
|
14.1
|
0.2
|
1
%
|
41.1
|
42.2
|
(1.1)
|
(3)
%
|
|||||||
|
Total expenses
|
199.7
|
311.9
|
(112.2)
|
(36)
%
|
909.8
|
970.6
|
(60.8)
|
(6)
%
|
|||||||
|
(=) Distributable Earnings
|
$
146.8
|
$
235.5
|
$
(88.7)
|
(38)
%
|
$
644.3
|
$
747.7
|
$
(103.4)
|
(14)
%
|
|||||||
|
(-) Realized Net Performance
Revenues
|
13.8
|
83.7
|
(69.9)
|
(84)
%
|
214.3
|
271.5
|
(57.2)
|
(21)
%
|
|||||||
|
(-) Realized Principal Investment
Income (loss)
|
(0.4)
|
10.0
|
(10.4)
|
NM
|
27.1
|
35.7
|
(8.6)
|
(24)
%
|
|||||||
|
(+) Net Interest
|
6.9
|
6.4
|
0.5
|
8
%
|
22.2
|
20.4
|
1.8
|
9
%
|
|||||||
|
(=) Fee Related Earnings
|
$
140.3
|
$
148.2
|
$
(7.9)
|
(5)
%
|
$
425.1
|
$
460.9
|
$
(35.8)
|
(8)
%
|
|||||||
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
||
|
2025 v. 2024
|
|||
|
(Dollars in millions)
|
|||
|
Distributable Earnings, September 30, 2024
|
$
235.5
|
$
747.7
|
|
|
Increases (decreases):
|
|||
|
Decrease in fee related earnings
|
(7.9)
|
(35.8)
|
|
|
Decrease in realized net performance revenues
|
(69.9)
|
(57.2)
|
|
|
Decrease in realized principal investment income
|
(10.4)
|
(8.6)
|
|
|
Increase in net interest
|
(0.5)
|
(1.8)
|
|
|
Total decrease
|
(88.7)
|
(103.4)
|
|
|
Distributable Earnings, September 30, 2025
|
$
146.8
|
$
644.3
|
|
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
||
|
2025 v. 2024
|
|||
|
(Dollars in millions)
|
|||
|
Fee Related Earnings, September 30, 2024
|
$
148.2
|
$
460.9
|
|
|
Increases (decreases):
|
|||
|
Decrease in fee revenues
|
(3.0)
|
(23.8)
|
|
|
Decrease in cash-based compensation and benefits
|
3.7
|
7.8
|
|
|
Increase in general, administrative and other indirect expenses
|
(7.7)
|
(17.9)
|
|
|
All other changes
|
(0.9)
|
(1.9)
|
|
|
Total decrease
|
(7.9)
|
(35.8)
|
|
|
Fee Related Earnings, September 30, 2025
|
$
140.3
|
$
425.1
|
|
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
||
|
2025 v. 2024
|
|||
|
(Dollars in millions)
|
|||
|
Lower fund management fees
|
$
(3.6)
|
$
(28.0)
|
|
|
Higher portfolio advisory and transaction fees, net and other
|
0.6
|
11.1
|
|
|
Lower fee related performance revenues
|
—
|
(6.9)
|
|
|
Total decrease in fee revenues
|
$
(3.0)
|
$
(23.8)
|
|
|
|
As of September 30,
|
||
|
|
2025
|
2024
|
|
|
Global Private Equity
|
(Dollars in millions)
|
||
|
Components of Fee-earning AUM
(1)
|
|||
|
Fee-earning AUM based on capital commitments
|
$
41,525
|
$
48,295
|
|
|
Fee-earning AUM based on invested capital
|
49,232
|
44,665
|
|
|
Fee-earning AUM based on net asset value
|
7,472
|
7,200
|
|
|
Fee-earning AUM based on lower of cost or fair value
|
2,918
|
3,363
|
|
|
Total Fee-earning AUM
|
$
101,147
|
$
103,523
|
|
|
Annualized Management Fee Rate
(2)
|
1.17
%
|
1.15
%
|
|
|
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||
|
|
2025
|
2024
|
2025
|
2024
|
|||
|
Global Private Equity
|
(Dollars in millions)
|
||||||
|
Fee-earning AUM Rollforward
|
|||||||
|
Balance, Beginning of Period
|
$
102,330
|
$
103,662
|
$
98,033
|
$
106,651
|
|||
|
Inflows
(1)
|
413
|
508
|
11,079
|
4,192
|
|||
|
Outflows (including realizations)
(2)
|
(1,583)
|
(1,376)
|
(9,599)
|
(7,246)
|
|||
|
Market Activity & Other
(3)
|
97
|
(42)
|
(161)
|
(150)
|
|||
|
Foreign Exchange
(4)
|
(110)
|
771
|
1,795
|
76
|
|||
|
Balance, End of Period
|
$
101,147
|
$
103,523
|
$
101,147
|
$
103,523
|
|||
|
|
Three Months Ended
September 30, 2025
|
Nine Months Ended
September 30, 2025
|
|
|
|
(Dollars in millions)
|
||
|
Global Private Equity
|
|||
|
Total AUM Rollforward
|
|||
|
Balance, Beginning of Period
|
$
165,057
|
$
163,533
|
|
|
Inflows
(1)
|
646
|
6,202
|
|
|
Outflows (including realizations)
(2)
|
(2,685)
|
(12,335)
|
|
|
Market Activity & Other
(3)
|
589
|
3,068
|
|
|
Foreign Exchange
(4)
|
(157)
|
2,982
|
|
|
Balance, End of Period
|
$
163,450
|
$
163,450
|
|
|
(Amounts in millions)
|
TOTAL INVESTMENTS
|
REALIZED/PARTIALLY
REALIZED INVESTMENTS(12)
|
||||||||||||
|
|
As of September 30, 2025
|
As of September 30, 2025
|
||||||||||||
|
Fund (Fee Initiation Date/Step-down Date)(1)
|
Committed
Capital(2)
|
Cumulative
Invested
Capital(3)
|
Percent
Invested
|
Realized
Value(4)
|
Remaining
Fair
Value(5)
|
MOIC
(6)
|
Gross
IRR
(7)(8)
|
Net
IRR
(8)(9)
|
Net Accrued
Carry/
(Giveback)
(10)
|
Total
Fair
Value(11)
|
MOIC
(6)
|
Gross
IRR
(7)(8)
|
||
|
Corporate Private Equity
|
||||||||||||||
|
CP VIII (Oct 2021 / Oct 2027)
|
$
14,797
|
$
10,603
|
72%
|
$
1,691
|
$
13,028
|
1.4x
|
19%
|
9%
|
$
157
|
$
2,161
|
1.7x
|
58%
|
||
|
CP VII (May 2018 / Oct 2021)
|
$
18,510
|
$
17,787
|
96%
|
$
7,864
|
$
21,235
|
1.6x
|
11%
|
8%
|
$
438
|
$
7,791
|
1.7x
|
13%
|
||
|
CP VI (May 2013 / May 2018)
|
$
13,000
|
$
13,140
|
101%
|
$
25,565
|
$
3,064
|
2.2x
|
18%
|
13%
|
$
126
|
$
26,348
|
2.5x
|
22%
|
||
|
CP V (Jun 2007 / May 2013)
|
$
13,720
|
$
13,238
|
96%
|
$
28,117
|
$
451
|
2.2x
|
18%
|
14%
|
$
31
|
$
28,136
|
2.3x
|
20%
|
||
|
CEP V (Oct 2018 / Oct 2024)
|
€
6,416
|
€
6,081
|
95%
|
€
1,626
|
€
4,981
|
1.1x
|
1%
|
Neg
|
$
—
|
€
541
|
0.8x
|
Neg
|
||
|
CEP IV (Sep 2014 / Oct 2018)
|
€
3,670
|
€
3,966
|
108%
|
€
6,210
|
€
1,331
|
1.9x
|
16%
|
11%
|
$
58
|
€
6,250
|
2.1x
|
20%
|
||
|
CEP III (Jul 2007 / Dec 2013)
|
€
5,295
|
€
5,177
|
98%
|
€
11,730
|
€
19
|
2.3x
|
19%
|
14%
|
$
2
|
€
11,749
|
2.3x
|
19%
|
||
|
CAP VI (Jun 2024 / Jun 2030)
|
$
2,852
|
$
—
|
—%
|
$
—
|
$
—
|
n/a
|
n/a
|
n/a
|
$
—
|
n/a
|
n/a
|
n/a
|
||
|
CAP V (Jun 2018 / Jun 2024)
|
$
6,554
|
$
6,875
|
105%
|
$
3,018
|
$
6,606
|
1.4x
|
13%
|
8%
|
$
3
|
$
2,142
|
1.3x
|
23%
|
||
|
CAP IV (Jul 2013 / Jun 2018)
|
$
3,880
|
$
4,146
|
107%
|
$
8,667
|
$
303
|
2.2x
|
18%
|
13%
|
$
18
|
$
8,704
|
2.4x
|
21%
|
||
|
CJP V (Nov 2024 / Nov 2030)
|
¥
434,325
|
¥
—
|
—%
|
¥
—
|
¥
—
|
n/a
|
n/a
|
n/a
|
$
—
|
n/a
|
n/a
|
n/a
|
||
|
CJP IV (Oct 2020 / Nov 2024)
|
¥
258,000
|
¥
234,357
|
91%
|
¥
148,550
|
¥
297,425
|
1.9x
|
36%
|
24%
|
$
86
|
¥
180,929
|
3.4x
|
64%
|
||
|
CJP III (Sep 2013 / Aug 2020)
|
¥
119,505
|
¥
91,192
|
76%
|
¥
273,641
|
¥
10,454
|
3.1x
|
25%
|
18%
|
$
5
|
¥
274,341
|
3.3x
|
26%
|
||
|
CGFSP III (Dec 2017 / Dec 2023)
|
$
1,005
|
$
977
|
97%
|
$
532
|
$
1,733
|
2.3x
|
22%
|
16%
|
$
78
|
$
1,035
|
4.1x
|
34%
|
||
|
CGFSP II (Jun 2013 / Dec 2017)
|
$
1,000
|
$
943
|
94%
|
$
1,961
|
$
638
|
2.8x
|
26%
|
19%
|
$
37
|
$
1,956
|
2.4x
|
28%
|
||
|
CP Growth (Oct 2021 / Oct 2027)
|
$
1,283
|
$
673
|
52%
|
$
—
|
$
812
|
1.2x
|
NM
|
NM
|
$
—
|
n/a
|
n/a
|
n/a
|
||
|
CEOF II (Nov 2015 / Mar 2020)
|
$
2,400
|
$
2,368
|
99%
|
$
4,107
|
$
1,437
|
2.3x
|
21%
|
15%
|
$
72
|
$
4,673
|
2.5x
|
23%
|
||
|
CETP V (Mar 2022 / Jun 2028)
|
€
3,180
|
€
1,528
|
48%
|
€
—
|
€
1,765
|
1.2x
|
NM
|
NM
|
$
—
|
n/a
|
n/a
|
n/a
|
||
|
CETP IV (Jul 2019 / Jun 2022)
|
€
1,350
|
€
1,201
|
89%
|
€
1,345
|
€
1,423
|
2.3x
|
30%
|
21%
|
$
60
|
€
1,344
|
4.4x
|
74%
|
||
|
CETP III (Jul 2014 / Jul 2019)
|
€
657
|
€
610
|
93%
|
€
1,752
|
€
333
|
3.4x
|
40%
|
28%
|
$
20
|
€
1,757
|
3.8x
|
45%
|
||
|
CGP II (Dec 2020 / Jan 2025)
|
$
1,840
|
$
984
|
53%
|
$
198
|
$
1,859
|
2.1x
|
24%
|
19%
|
$
42
|
n/a
|
n/a
|
n/a
|
||
|
CGP (Jan 2015 / Mar 2021)
|
$
3,588
|
$
3,235
|
90%
|
$
1,583
|
$
2,738
|
1.3x
|
4%
|
3%
|
$
16
|
$
1,817
|
2.3x
|
16%
|
||
|
All Other Active Funds & Vehicles(13)
|
$
20,790
|
n/a
|
$
15,495
|
$
17,090
|
1.6x
|
12%
|
10%
|
$
45
|
$
15,526
|
2.0x
|
18%
|
|||
|
Fully Realized Funds & Vehicles(14)(15)
|
$
35,574
|
n/a
|
$
81,709
|
$
2
|
2.3x
|
28%
|
20%
|
$
2
|
$
81,711
|
2.3x
|
28%
|
|||
|
TOTAL CORPORATE PRIVATE EQUITY(16)
|
$
155,358
|
n/a
|
$
210,005
|
$
84,661
|
1.9x
|
25%
|
17%
|
$
1,295
|
$
210,523
|
2.3x
|
26%
|
|||
|
Real Estate
|
||||||||||||||
|
CRP X (Apr 2025 / Jul 2030)
|
$
9,000
|
$
372
|
4%
|
$
—
|
$
360
|
1.0x
|
NM
|
NM
|
$
—
|
n/a
|
n/a
|
n/a
|
||
|
CRP IX (Oct 2021 / Dec 2024)
|
$
7,987
|
$
6,012
|
75%
|
$
432
|
$
6,722
|
1.2x
|
12%
|
3%
|
$
—
|
$
409
|
1.4x
|
25%
|
||
|
CRP VIII (Aug 2017 / Oct 2021)
|
$
5,505
|
$
5,123
|
93%
|
$
5,677
|
$
3,251
|
1.7x
|
32%
|
18%
|
$
87
|
$
5,624
|
2.1x
|
49%
|
||
|
CRP VII (Jun 2014 / Dec 2017)
|
$
4,162
|
$
3,821
|
92%
|
$
5,098
|
$
1,169
|
1.6x
|
16%
|
10%
|
$
—
|
$
5,063
|
1.7x
|
20%
|
||
|
CRP VI (Mar 2011 / Jun 2014)
|
$
2,340
|
$
2,155
|
92%
|
$
3,815
|
$
118
|
1.8x
|
27%
|
17%
|
$
4
|
$
3,748
|
1.9x
|
28%
|
||
|
CPI (May 2016 / n/a)
|
$
8,249
|
$
8,706
|
106%
|
$
3,390
|
$
7,965
|
1.3x
|
10%
|
8%
|
n/a*
|
$
2,161
|
1.7x
|
12%
|
||
|
All Other Active Funds & Vehicles(17)
|
$
2,599
|
n/a
|
$
505
|
$
2,498
|
1.2x
|
9%
|
5%
|
$
5
|
$
340
|
1.1x
|
20%
|
|||
|
Fully Realized Funds & Vehicles(15)(18)
|
$
14,293
|
n/a
|
$
21,641
|
$
13
|
1.5x
|
9%
|
5%
|
$
—
|
$
21,654
|
1.5x
|
10%
|
|||
|
TOTAL REAL ESTATE(16)
|
$
43,082
|
n/a
|
$
40,558
|
$
22,095
|
1.5x
|
11%
|
7%
|
$
96
|
$
38,998
|
1.6x
|
13%
|
|||
|
Infrastructure & Natural Resources
|
||||||||||||||
|
CIEP II (Apr 2019 / Apr 2025)
|
$
2,286
|
$
1,008
|
44%
|
$
799
|
$
1,098
|
1.9x
|
26%
|
12%
|
$
36
|
$
752
|
3.2x
|
NM**
|
||
|
CIEP I (Sep 2013 / Jun 2019)
|
$
2,500
|
$
2,470
|
99%
|
$
3,372
|
$
1,374
|
1.9x
|
15%
|
9%
|
$
48
|
$
3,750
|
2.2x
|
18%
|
||
|
CGIOF (Dec 2018 / Sep 2023)
|
$
2,201
|
$
2,098
|
95%
|
$
658
|
$
2,926
|
1.7x
|
18%
|
11%
|
$
82
|
$
792
|
1.8x
|
16%
|
||
|
CRSEF II (Nov 2022 / Aug 2027)
|
$
1,187
|
$
492
|
41%
|
$
—
|
$
835
|
1.7x
|
NM
|
NM
|
$
16
|
n/a
|
n/a
|
n/a
|
||
|
NGP XIII (Feb 2023 / Feb 2028)
|
$
2,300
|
$
491
|
21%
|
$
49
|
$
732
|
1.6x
|
NM
|
NM
|
$
4
|
$
91
|
3.3x
|
NM
|
||
|
NGP XII (Jul 2017 / Jul 2022)
|
$
4,304
|
$
3,652
|
85%
|
$
4,779
|
$
2,747
|
2.1x
|
21%
|
15%
|
$
32
|
$
4,456
|
2.8x
|
33%
|
||
|
NGP XI (Oct 2014 / Jul 2017)
|
$
5,325
|
$
5,034
|
95%
|
$
8,112
|
$
1,709
|
2.0x
|
13%
|
10%
|
$
64
|
$
7,380
|
2.1x
|
17%
|
||
|
NGP X (Jan 2012 / Dec 2014)
|
$
3,586
|
$
3,351
|
93%
|
$
3,458
|
$
307
|
1.1x
|
3%
|
—%
|
$
—
|
$
3,272
|
1.2x
|
5%
|
||
|
All Other Active Funds & Vehicles(19)
|
$
5,029
|
n/a
|
$
3,191
|
$
4,783
|
1.6x
|
15%
|
12%
|
$
31
|
$
3,156
|
2.3x
|
19%
|
|||
|
Fully Realized Funds & Vehicles(15)(20)
|
$
3,534
|
n/a
|
$
5,574
|
$
6
|
1.6x
|
8%
|
5%
|
$
1
|
$
5,579
|
1.6x
|
8%
|
|||
|
TOTAL INFRASTRUCTURE & NATURAL
RESOURCES(16)
|
$
27,157
|
n/a
|
$
29,991
|
$
16,516
|
1.7x
|
12%
|
8%
|
$
314
|
$
29,228
|
1.9x
|
14%
|
|||
|
|
Three Months Ended
September 30,
|
Change
|
Nine Months Ended
September 30,
|
Change
|
|||||||||||
|
|
2025
|
2024
|
$
|
%
|
2025
|
2024
|
$
|
%
|
|||||||
|
|
(Dollars in millions)
|
||||||||||||||
|
Segment Revenues
|
|||||||||||||||
|
Fund level fee revenues
|
|||||||||||||||
|
Fund management fees
|
$
146.5
|
$
142.8
|
$
3.7
|
3
%
|
$
456.1
|
$
420.5
|
$
35.6
|
8
%
|
|||||||
|
Portfolio advisory and
transaction fees, net and other
|
25.6
|
21.4
|
4.2
|
20
%
|
130.0
|
66.0
|
64.0
|
97
%
|
|||||||
|
Fee related performance
revenues
|
28.6
|
29.0
|
(0.4)
|
(1)
%
|
86.0
|
81.2
|
4.8
|
6
%
|
|||||||
|
Total fund level fee revenues
|
200.7
|
193.2
|
7.5
|
4
%
|
672.1
|
567.7
|
104.4
|
18
%
|
|||||||
|
Realized performance revenues
|
8.2
|
11.5
|
(3.3)
|
(29)
%
|
26.6
|
19.0
|
7.6
|
40
%
|
|||||||
|
Realized principal investment
income (loss)
|
42.8
|
(2.8)
|
45.6
|
NM
|
60.3
|
30.2
|
30.1
|
100
%
|
|||||||
|
Interest income
|
8.1
|
9.8
|
(1.7)
|
(17)
%
|
22.1
|
30.6
|
(8.5)
|
(28)
%
|
|||||||
|
Total revenues
|
259.8
|
211.7
|
48.1
|
23
%
|
781.1
|
647.5
|
133.6
|
21
%
|
|||||||
|
Segment Expenses
|
|||||||||||||||
|
Compensation and benefits
|
|||||||||||||||
|
Cash-based compensation and
benefits
|
83.8
|
76.5
|
7.3
|
10
%
|
261.0
|
227.3
|
33.7
|
15
%
|
|||||||
|
Realized performance revenues
related compensation
|
4.7
|
6.9
|
(2.2)
|
(32)
%
|
15.7
|
11.5
|
4.2
|
37
%
|
|||||||
|
Total compensation and
benefits
|
88.5
|
83.4
|
5.1
|
6
%
|
276.7
|
238.8
|
37.9
|
16
%
|
|||||||
|
General, administrative, and other
indirect expenses
|
28.5
|
31.2
|
(2.7)
|
(9)
%
|
99.7
|
96.1
|
3.6
|
4
%
|
|||||||
|
Depreciation and amortization
expense
|
4.3
|
3.3
|
1.0
|
30
%
|
12.0
|
9.6
|
2.4
|
25
%
|
|||||||
|
Interest expense
|
12.1
|
13.3
|
(1.2)
|
(9)
%
|
34.9
|
40.6
|
(5.7)
|
(14)
%
|
|||||||
|
Total expenses
|
133.4
|
131.2
|
2.2
|
2
%
|
423.3
|
385.1
|
38.2
|
10
%
|
|||||||
|
(=) Distributable Earnings
|
$
126.4
|
$
80.5
|
$
45.9
|
57
%
|
$
357.8
|
$
262.4
|
$
95.4
|
36
%
|
|||||||
|
(-) Realized Net Performance
Revenues
|
3.5
|
4.6
|
(1.1)
|
(24)
%
|
10.9
|
7.5
|
3.4
|
45
%
|
|||||||
|
(-) Realized Principal Investment
Income (loss)
|
42.8
|
(2.8)
|
45.6
|
NM
|
60.3
|
30.2
|
30.1
|
100
%
|
|||||||
|
(+) Net Interest
|
4.0
|
3.5
|
0.5
|
14
%
|
12.8
|
10.0
|
2.8
|
28
%
|
|||||||
|
(=) Fee Related Earnings
|
$
84.1
|
$
82.2
|
$
1.9
|
2
%
|
$
299.4
|
$
234.7
|
$
64.7
|
28
%
|
|||||||
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
||
|
2025 v. 2024
|
|||
|
(Dollars in millions)
|
|||
|
Distributable Earnings, September 30, 2024
|
$
80.5
|
$
262.4
|
|
|
Increases (decreases):
|
|||
|
Increase in fee related earnings
|
1.9
|
64.7
|
|
|
(Decrease) increase in realized net performance revenues
|
(1.1)
|
3.4
|
|
|
Increase in realized principal investment income
|
45.6
|
30.1
|
|
|
Increase in net interest
|
(0.5)
|
(2.8)
|
|
|
Total increase
|
45.9
|
95.4
|
|
|
Distributable Earnings, September 30, 2025
|
$
126.4
|
$
357.8
|
|
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
||
|
2025 v. 2024
|
|||
|
(Dollars in millions)
|
|||
|
Fee Related Earnings, September 30, 2024
|
$
82.2
|
$
234.7
|
|
|
Increases (decreases):
|
|||
|
Increase in fee revenues
|
7.5
|
104.4
|
|
|
Increase in cash-based compensation and benefits
|
(7.3)
|
(33.7)
|
|
|
Decrease (increase) in general, administrative and other indirect expenses
|
2.7
|
(3.6)
|
|
|
All other changes
|
(1.0)
|
(2.4)
|
|
|
Total increase
|
1.9
|
64.7
|
|
|
Fee Related Earnings, September 30, 2025
|
$
84.1
|
$
299.4
|
|
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
||
|
2025 v. 2024
|
|||
|
(Dollars in millions)
|
|||
|
Higher fund management fees
|
$
3.7
|
$
35.6
|
|
|
Higher portfolio advisory and transaction fees, net and other
|
4.2
|
64.0
|
|
|
(Lower) higher fee related performance revenues
|
(0.4)
|
4.8
|
|
|
Total increase in fee revenues
|
$
7.5
|
$
104.4
|
|
|
|
As of September 30,
|
||
|
|
2025
|
2024
|
|
|
Global Credit
|
(Dollars in millions)
|
||
|
Components of Fee-earning AUM
(1)
|
|||
|
Fee-earning AUM based on capital commitments
|
$
2,504
|
$
2,467
|
|
|
Fee-earning AUM based on invested capital
|
21,110
|
19,220
|
|
|
Fee-earning AUM based on collateral balances, at par
|
43,929
|
46,454
|
|
|
Fee-earning AUM based on net asset value
|
3,821
|
2,409
|
|
|
Fee-earning AUM based on fair value and other
(2)
|
95,800
|
88,611
|
|
|
Total Fee-earning AUM
|
$
167,164
|
$
159,161
|
|
|
Annualized Management Fee Rate
(3)
|
0.37
%
|
0.36
%
|
|
|
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||
|
|
2025
|
2024
|
2025
|
2024
|
|||
|
Global Credit
|
(Dollars in millions)
|
||||||
|
Fee-earning AUM Rollforward
|
|||||||
|
Balance, Beginning of Period
|
$
162,784
|
$
155,437
|
$
154,186
|
$
155,238
|
|||
|
Inflows
(1)
|
8,983
|
2,594
|
21,264
|
10,216
|
|||
|
Outflows (including realizations)
(2)
|
(4,878)
|
(3,137)
|
(11,406)
|
(8,901)
|
|||
|
Market Activity & Other
(3)
|
278
|
3,868
|
1,980
|
2,553
|
|||
|
Foreign Exchange
(4)
|
(3)
|
399
|
1,140
|
55
|
|||
|
Balance, End of Period
|
$
167,164
|
$
159,161
|
$
167,164
|
$
159,161
|
|||
|
|
Three Months Ended
September 30, 2025
|
Nine Months Ended
September 30, 2025
|
|
|
|
(Dollars in millions)
|
||
|
Global Credit
|
|||
|
Total AUM Rollforward
|
|||
|
Balance, Beginning of Period
|
$
203,027
|
$
192,374
|
|
|
Inflows
(1)
|
9,900
|
22,882
|
|
|
Outflows (including realizations)
(2)
|
(6,331)
|
(13,065)
|
|
|
Market Activity & Other
(3)
|
1,877
|
5,049
|
|
|
Foreign Exchange
(4)
|
1
|
1,234
|
|
|
Balance, End of Period
|
$
208,474
|
$
208,474
|
|
|
(Dollars in millions)
|
|
TOTAL INVESTMENTS
|
||||||||
|
|
|
As of September 30, 2025
|
||||||||
|
Fund (Fee Initiation Date/Step-down Date)(11)
|
Committed
Capital(12)
|
Cumulative
Invested
Capital (1)
|
Percent
Invested
|
Realized
Value (2)
|
Remaining
Fair Value
(3)
|
MOIC (4)
|
Gross IRR
(5) (8)
|
Net IRR
(6) (8)
|
Net Accrued
Carry/(Giveback)
(7)
|
|
|
Global Credit Carry Funds
|
||||||||||
|
CCOF III - Levered (Feb 2023 / Oct 2028)
|
$
4,678
|
$
3,558
|
76%
|
$
589
|
$
3,540
|
1.2x
|
NM
|
NM
|
$
19
|
|
|
CCOF II (Nov 2020 / Mar 2026)
|
$
4,430
|
$
5,846
|
132%
|
$
3,585
|
$
4,466
|
1.4x
|
14%
|
10%
|
$
121
|
|
|
CCOF I (Nov 2017 / Sep 2022)
|
$
2,373
|
$
3,514
|
148%
|
$
3,818
|
$
1,253
|
1.4x
|
16%
|
12%
|
$
31
|
|
|
CSP IV (Apr 2016 / Dec 2020)
|
$
2,500
|
$
2,500
|
100%
|
$
1,667
|
$
1,852
|
1.4x
|
10%
|
5%
|
$
—
|
|
|
CICF II (Mar 2024 / Dec 2029)
|
$
1,379
|
$
265
|
19%
|
$
35
|
$
259
|
1.1x
|
NM
|
NM
|
$
1
|
|
|
SASOF III (Nov 2014 / n/a)
|
$
833
|
$
991
|
119%
|
$
1,267
|
$
91
|
1.4x
|
19%
|
12%
|
$
7
|
|
|
All Other Active Funds & Vehicles(9)
|
$
12,464
|
n/a
|
$
4,302
|
$
11,035
|
1.2x
|
11%
|
9%
|
$
88
|
||
|
Fully Realized Funds & Vehicles(10)(13)
|
$
9,698
|
n/a
|
$
12,155
|
$
35
|
1.3x
|
9%
|
4%
|
$
—
|
||
|
TOTAL GLOBAL CREDIT CARRY FUNDS
|
$
38,835
|
n/a
|
$
27,419
|
$
22,530
|
1.3x
|
11%
|
7%
|
$
266
|
||
|
|
Three Months Ended
September 30,
|
Change
|
Nine Months Ended
September 30,
|
Change
|
|||||||||||
|
|
2025
|
2024
|
$
|
%
|
2025
|
2024
|
$
|
%
|
|||||||
|
|
(Dollars in millions)
|
||||||||||||||
|
Segment Revenues
|
|||||||||||||||
|
Fund level fee revenues
|
|||||||||||||||
|
Fund management fees
|
$
132.4
|
$
85.1
|
$
47.3
|
56
%
|
$
352.5
|
$
238.7
|
$
113.8
|
48
%
|
|||||||
|
Portfolio advisory and
transaction fees, net and other
|
0.2
|
0.1
|
0.1
|
100
%
|
0.2
|
0.2
|
—
|
—
%
|
|||||||
|
Fee related performance
revenues
|
18.9
|
7.3
|
11.6
|
159
%
|
39.7
|
10.4
|
29.3
|
282
%
|
|||||||
|
Total fund level fee revenues
|
151.5
|
92.5
|
59.0
|
64
%
|
392.4
|
249.3
|
143.1
|
57
%
|
|||||||
|
Realized performance revenues
|
15.5
|
39.2
|
(23.7)
|
(60)
%
|
50.2
|
82.5
|
(32.3)
|
(39)
%
|
|||||||
|
Realized principal investment
income
|
7.1
|
1.9
|
5.2
|
274
%
|
25.6
|
3.5
|
22.1
|
NM
|
|||||||
|
Interest income
|
2.1
|
2.3
|
(0.2)
|
(9)
%
|
6.3
|
5.8
|
0.5
|
9
%
|
|||||||
|
Total revenues
|
176.2
|
135.9
|
40.3
|
30
%
|
474.5
|
341.1
|
133.4
|
39
%
|
|||||||
|
Segment Expenses
|
|||||||||||||||
|
Compensation and benefits
|
|||||||||||||||
|
Cash-based compensation and
benefits
|
39.3
|
30.0
|
9.3
|
31
%
|
110.8
|
85.6
|
25.2
|
29
%
|
|||||||
|
Realized performance revenues
related compensation
|
13.7
|
36.9
|
(23.2)
|
(63)
%
|
41.2
|
73.2
|
(32.0)
|
(44)
%
|
|||||||
|
Total compensation and
benefits
|
53.0
|
66.9
|
(13.9)
|
(21)
%
|
152.0
|
158.8
|
(6.8)
|
(4)
%
|
|||||||
|
General, administrative, and other
indirect expenses
|
22.6
|
13.2
|
9.4
|
71
%
|
54.3
|
37.1
|
17.2
|
46
%
|
|||||||
|
Depreciation and amortization
expense
|
2.1
|
1.8
|
0.3
|
17
%
|
6.0
|
5.0
|
1.0
|
20
%
|
|||||||
|
Interest expense
|
3.3
|
2.9
|
0.4
|
14
%
|
9.5
|
8.7
|
0.8
|
9
%
|
|||||||
|
Total expenses
|
81.0
|
84.8
|
(3.8)
|
(4)
%
|
221.8
|
209.6
|
12.2
|
6
%
|
|||||||
|
(=) Distributable Earnings
|
$
95.2
|
$
51.1
|
$
44.1
|
86
%
|
$
252.7
|
$
131.5
|
$
121.2
|
92
%
|
|||||||
|
(-) Realized Net Performance
Revenues
|
1.8
|
2.3
|
(0.5)
|
(22)
%
|
9.0
|
9.3
|
(0.3)
|
(3)
%
|
|||||||
|
(-) Realized Principal Investment
Income
|
7.1
|
1.9
|
5.2
|
274
%
|
25.6
|
3.5
|
22.1
|
NM
|
|||||||
|
(+) Net Interest
|
1.2
|
0.6
|
0.6
|
100
%
|
3.2
|
2.9
|
0.3
|
10
%
|
|||||||
|
(=) Fee Related Earnings
|
$
87.5
|
$
47.5
|
$
40.0
|
84
%
|
$
221.3
|
$
121.6
|
$
99.7
|
82
%
|
|||||||
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
||
|
2025 v. 2024
|
|||
|
(Dollars in millions)
|
|||
|
Distributable Earnings, September 30, 2024
|
$
51.1
|
$
131.5
|
|
|
Increases (decreases):
|
|||
|
Increase in fee related earnings
|
40.0
|
99.7
|
|
|
Decrease in realized net performance revenues
|
(0.5)
|
(0.3)
|
|
|
Increase in realized principal investment income
|
5.2
|
22.1
|
|
|
Increase in net interest
|
(0.6)
|
(0.3)
|
|
|
Total increase
|
44.1
|
121.2
|
|
|
Distributable Earnings, September 30, 2025
|
$
95.2
|
$
252.7
|
|
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
||
|
2025 v. 2024
|
|||
|
(Dollars in millions)
|
|||
|
Fee Related Earnings, September 30, 2024
|
$
47.5
|
$
121.6
|
|
|
Increases (decreases):
|
|||
|
Increase in fee revenues
|
59.0
|
143.1
|
|
|
Increase in cash-based compensation and benefits
|
(9.3)
|
(25.2)
|
|
|
Increase in general, administrative and other indirect expenses
|
(9.4)
|
(17.2)
|
|
|
All other changes
|
(0.3)
|
(1.0)
|
|
|
Total increase
|
40.0
|
99.7
|
|
|
Fee Related Earnings, September 30, 2025
|
$
87.5
|
$
221.3
|
|
|
|
As of September 30,
|
||
|
|
2025
|
2024
|
|
|
Carlyle AlpInvest
|
(Dollars in millions)
|
||
|
Components of Fee-earning AUM
(1)
|
|||
|
Fee-earning AUM based on capital commitments
|
$
27,966
|
$
20,485
|
|
|
Fee-earning AUM based on invested capital
(2)
|
8,968
|
9,205
|
|
|
Fee-earning AUM based on net asset value
|
17,051
|
12,383
|
|
|
Fee-earning AUM based on lower of cost or fair market value and other
|
9,658
|
8,850
|
|
|
Total Fee-earning AUM
|
$
63,643
|
$
50,923
|
|
|
Annualized Management Fee Rate
(3)
|
0.69
%
|
0.65
%
|
|
|
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||
|
|
2025
|
2024
|
2025
|
2024
|
|||
|
Carlyle AlpInvest
|
(Dollars in millions)
|
||||||
|
Fee-earning AUM Rollforward
|
|||||||
|
Balance, Beginning of Period
|
$
59,587
|
$
48,246
|
$
52,139
|
$
45,529
|
|||
|
Inflows
(1)
|
4,696
|
2,257
|
11,653
|
6,851
|
|||
|
Outflows (including realizations)
(2)
|
(1,102)
|
(616)
|
(2,969)
|
(2,435)
|
|||
|
Market Activity & Other
(3)
|
473
|
358
|
668
|
832
|
|||
|
Foreign Exchange
(4)
|
(11)
|
678
|
2,152
|
146
|
|||
|
Balance, End of Period
|
$
63,643
|
$
50,923
|
$
63,643
|
$
50,923
|
|||
|
|
Three Months Ended
September 30, 2025
|
Nine Months Ended
September 30, 2025
|
|
|
|
(Dollars in millions)
|
||
|
Carlyle AlpInvest
|
|||
|
Total AUM Rollforward
|
|||
|
Balance, Beginning of Period
|
$
96,518
|
$
85,113
|
|
|
Inflows
(1)
|
6,318
|
15,392
|
|
|
Outflows (including realizations)
(2)
|
(2,715)
|
(6,346)
|
|
|
Market Activity & Other
(3)
|
2,062
|
4,279
|
|
|
Foreign Exchange
(4)
|
(48)
|
3,697
|
|
|
Balance, End of Period
|
$
102,135
|
$
102,135
|
|
|
(Amounts in millions)
|
|
|
TOTAL INVESTMENTS
|
|||||||||
|
|
|
|
As of September 30, 2025
|
|||||||||
|
Carlyle AlpInvest (1)(8)
|
Vintage
Year
|
Fund Size
|
Cumulative
Invested
Capital
(2)(3)
|
Realized
Value (3)
|
Remaining
Fair Value
(3)
|
Total Fair
Value(3)(4)
|
MOIC
(5)
|
Gross
IRR
(6)(10)
|
Net
IRR
(7)(10)
|
Net Accrued
Carry/
(Giveback)
(12)
|
||
|
|
|
|
(Reported in Local Currency, in Millions)
|
|||||||||
|
Secondaries &
Portfolio
Finance
|
ASF VIII
|
2024
|
$
13,422
|
$
5,576
|
$
149
|
$
7,138
|
$
7,287
|
1.3x
|
NM
|
NM
|
$
56
|
|
|
ASF VII
|
2020
|
$
6,769
|
$
4,926
|
$
1,993
|
$
5,839
|
$
7,832
|
1.6x
|
18%
|
14%
|
$
118
|
||
|
ASF VII - SMAs
|
2020
|
€
2,027
|
€
1,693
|
€
556
|
€
1,982
|
€
2,537
|
1.5x
|
16%
|
14%
|
$
38
|
||
|
ASF VI
|
2017
|
$
3,333
|
$
2,810
|
$
2,791
|
$
1,850
|
$
4,641
|
1.7x
|
15%
|
11%
|
$
59
|
||
|
ASF VI - SMAs
|
2017
|
€
2,817
|
€
2,613
|
€
2,396
|
€
1,796
|
€
4,192
|
1.6x
|
13%
|
12%
|
$
49
|
||
|
ASF V
|
2012
|
$
756
|
$
673
|
$
1,083
|
$
120
|
$
1,203
|
1.8x
|
18%
|
14%
|
$
5
|
||
|
ASF V - SMAs
|
2012
|
€
3,916
|
€
3,913
|
€
6,797
|
€
457
|
€
7,254
|
1.9x
|
21%
|
19%
|
$
10
|
||
|
SMAs 2009-2011
|
2010
|
€
1,859
|
€
1,929
|
€
3,328
|
€
37
|
€
3,366
|
1.7x
|
19%
|
18%
|
$
—
|
||
|
ASPF II
|
2023
|
$
2,227
|
$
707
|
$
255
|
$
609
|
$
864
|
1.2x
|
NM
|
NM
|
$
7
|
||
|
All Other Active Funds & Vehicles (9)
|
Various
|
$
2,015
|
$
861
|
$
1,911
|
$
2,772
|
1.4x
|
21%
|
18%
|
$
34
|
|||
|
Fully Realized Funds & Vehicles
|
Various
|
€
4,079
|
€
6,714
|
€
11
|
€
6,725
|
1.6x
|
19%
|
18%
|
$
—
|
|||
|
Co-Investments
|
ACF IX
|
2023
|
$
4,120
|
$
1,684
|
$
15
|
$
1,926
|
$
1,941
|
1.2x
|
NM
|
NM
|
$
3
|
|
|
ACF VIII
|
2021
|
$
3,614
|
$
3,458
|
$
417
|
$
4,481
|
$
4,899
|
1.4x
|
12%
|
10%
|
$
48
|
||
|
ACF VIII - SMAs
|
2021
|
$
1,079
|
$
1,000
|
$
115
|
$
1,290
|
$
1,405
|
1.4x
|
13%
|
11%
|
$
12
|
||
|
ACF VII
|
2017
|
$
1,688
|
$
1,668
|
$
1,425
|
$
1,929
|
$
3,354
|
2.0x
|
15%
|
13%
|
$
60
|
||
|
ACF VII - SMAs
|
2017
|
€
1,452
|
€
1,365
|
€
960
|
€
1,609
|
€
2,569
|
1.9x
|
14%
|
12%
|
$
43
|
||
|
SMAs 2014-2016
|
2014
|
€
1,274
|
€
1,064
|
€
2,280
|
€
436
|
€
2,716
|
2.6x
|
24%
|
22%
|
$
8
|
||
|
SMAs 2012-2013
|
2012
|
€
1,124
|
€
1,011
|
€
2,767
|
€
123
|
€
2,890
|
2.9x
|
28%
|
26%
|
$
1
|
||
|
SMAs 2009-2010
|
2010
|
€
1,475
|
€
1,317
|
€
3,494
|
€
392
|
€
3,886
|
2.9x
|
23%
|
21%
|
$
—
|
||
|
Strategic SMAs
|
Various
|
$
4,523
|
$
2,061
|
$
5,699
|
$
7,760
|
1.7x
|
16%
|
15%
|
$
81
|
|||
|
All Other Active Funds & Vehicles (9)
|
Various
|
€
283
|
€
166
|
€
260
|
€
425
|
1.5x
|
33%
|
31%
|
$
2
|
|||
|
Fully Realized Funds & Vehicles
|
Various
|
€
5,781
|
€
9,895
|
€
7
|
€
9,902
|
1.7x
|
15%
|
13%
|
$
—
|
|||
|
Primary
Investments
|
SMAs 2024-2026
|
2024
|
€
3,230
|
€
115
|
€
4
|
€
112
|
€
116
|
1.0x
|
NM
|
NM
|
$
—
|
|
|
SMAs 2021-2023
|
2021
|
€
4,535
|
€
1,606
|
€
105
|
€
1,837
|
€
1,942
|
1.2x
|
NM
|
NM
|
$
1
|
||
|
SMAs 2018-2020
|
2018
|
$
3,116
|
$
2,596
|
$
732
|
$
3,156
|
$
3,888
|
1.5x
|
15%
|
14%
|
$
4
|
||
|
SMAs 2015-2017
|
2015
|
€
2,501
|
€
2,447
|
€
2,704
|
€
2,186
|
€
4,891
|
2.0x
|
19%
|
19%
|
$
9
|
||
|
SMAs 2012-2014
|
2012
|
€
5,080
|
€
5,684
|
€
9,415
|
€
3,019
|
€
12,433
|
2.2x
|
17%
|
17%
|
$
11
|
||
|
SMAs 2009-2011
|
2009
|
€
4,877
|
€
5,520
|
€
10,323
|
€
1,736
|
€
12,060
|
2.2x
|
17%
|
17%
|
$
1
|
||
|
SMAs 2006-2008
|
2005
|
€
11,500
|
€
12,821
|
€
21,309
|
€
1,212
|
€
22,522
|
1.8x
|
10%
|
10%
|
$
—
|
||
|
SMAs 2003-2005
|
2003
|
€
4,628
|
€
4,877
|
€
7,762
|
€
135
|
€
7,897
|
1.6x
|
10%
|
9%
|
$
—
|
||
|
All Other Active Funds & Vehicles (9)
|
Various
|
€
1,741
|
€
1,748
|
€
227
|
€
1,975
|
1.1x
|
3%
|
2%
|
$
—
|
|||
|
Fully Realized Funds & Vehicles
|
Various
|
€
4,740
|
€
7,728
|
€
20
|
€
7,748
|
1.6x
|
12%
|
11%
|
$
—
|
|||
|
TOTAL CARLYLE ALPINVEST (USD)(11)
|
$
107,582
|
$
129,991
|
$
56,634
|
$
186,625
|
1.7x
|
14%
|
13%
|
$
660
|
||||
|
Accrued
Performance
Allocations
(1)
|
Accrued
Giveback
Obligation
|
Net Accrued
Performance
Revenues
|
|||
|
|
(Dollars in millions)
|
||||
|
Global Private Equity
|
$
4,352.3
|
$
(19.1)
|
$
4,333.2
|
||
|
Global Credit
|
721.1
|
(25.5)
|
695.6
|
||
|
Carlyle AlpInvest
|
1,882.9
|
—
|
1,882.9
|
||
|
Total
|
$
6,956.3
|
$
(44.6)
|
$
6,911.7
|
||
|
Plus: Accrued performance allocations from NGP Carry Funds
(2)
|
341.2
|
||||
|
Less: Accrued performance allocation-related compensation
|
(4,660.2)
|
||||
|
Plus: Receivable for giveback obligations from current and former employees
|
11.5
|
||||
|
Less: Deferred taxes on certain foreign accrued performance allocations
|
(19.9)
|
||||
|
Less/Plus: Net accrued performance allocations/giveback obligations attributable to non-controlling interests in
consolidated entities
|
(0.4)
|
||||
|
Plus: Net accrued performance allocations attributable to Consolidated Funds, eliminated in consolidation
|
22.6
|
||||
|
Net accrued performance revenues before timing differences
|
2,606.5
|
||||
|
Less/Plus: Timing differences between the period when accrued performance allocations/giveback obligations
are realized and the period they are collected/distributed
|
23.6
|
||||
|
Net accrued performance revenues attributable to The Carlyle Group Inc.
|
$
2,630.1
|
||||
|
Carry Fund Appreciation/(Depreciation)
(1)
|
Net Accrued
Performance
Revenues
|
||||||||||||
|
Quarter-to-Date
|
Year-to-Date
|
Last Twelve
Months
|
|||||||||||
|
Q3 2024
|
Q3 2025
|
Q3 2024
|
Q3 2025
|
Q3 2024
|
Q3 2025
|
||||||||
|
Overall Carry Fund Appreciation/(Depreciation)
|
3
%
|
2
%
|
7
%
|
5
%
|
8
%
|
7
%
|
|||||||
|
Global Private Equity:
|
4
%
|
1
%
|
6
%
|
4
%
|
7
%
|
5
%
|
$
1,704.7
|
||||||
|
Corporate Private Equity
|
4
%
|
—
%
|
7
%
|
3
%
|
9
%
|
4
%
|
1,295.3
|
||||||
|
Real Estate
|
2
%
|
1
%
|
4
%
|
3
%
|
2
%
|
4
%
|
95.7
|
||||||
|
Infrastructure & Natural Resources
|
2
%
|
5
%
|
7
%
|
12
%
|
6
%
|
12
%
|
313.7
|
||||||
|
Global Credit Carry Funds
|
3
%
|
4
%
|
9
%
|
12
%
|
14
%
|
16
%
|
265.9
|
||||||
|
Carlyle AlpInvest Carry Funds
|
2
%
|
2
%
|
6
%
|
5
%
|
8
%
|
8
%
|
659.5
|
||||||
|
Net Accrued Performance Revenues
|
$
2,630.1
|
||||||||||||
|
Investments in
Carlyle Funds
|
Investments
in NGP
(1)
|
Total
|
|||
|
(Dollars in millions)
|
|||||
|
Investments, excluding performance allocations
|
$
2,961.9
|
$
597.2
|
$
3,559.1
|
||
|
Less: Amounts attributable to non-controlling interests in consolidated entities
|
(380.8)
|
—
|
(380.8)
|
||
|
Plus: Investments in Consolidated Funds, eliminated in consolidation
|
898.1
|
—
|
898.1
|
||
|
Less: Strategic equity method investments in NGP Management
|
—
|
(256.0)
|
(256.0)
|
||
|
Less: Investment in NGP general partners - accrued performance allocations
|
—
|
(341.2)
|
(341.2)
|
||
|
Total investments attributable to The Carlyle Group Inc.
|
$
3,479.2
|
$
—
|
$
3,479.2
|
||
|
Investments in Carlyle Funds, excluding CLOs:
|
|
|
Global Private Equity funds
(1)
|
$
1,226.5
|
|
Global Credit funds
(2)
|
1,280.4
|
|
Carlyle AlpInvest funds
|
428.2
|
|
Total investments in Carlyle Funds, excluding CLOs
|
2,935.1
|
|
Investments in CLOs
|
405.9
|
|
Other investments
|
138.2
|
|
Total investments attributable to The Carlyle Group Inc.
|
3,479.2
|
|
CLO loans and other borrowings collateralized by investments attributable to The Carlyle Group Inc.
(3)
|
(318.3)
|
|
Total investments attributable to The Carlyle Group Inc., net of CLO loans and other borrowings
|
$
3,160.9
|
|
Common Stock Dividends - Dividend Year 2025
|
|||||
|
Quarter
|
Dividend per
Common Share
|
Dividend to
Common
Stockholders
|
Record Date
|
Payment Date
|
|
|
(Dollars in millions, except per share data)
|
|||||
|
Q1 2025
|
$
0.35
|
$
126.3
|
May 19, 2025
|
May 27, 2025
|
|
|
Q2 2025
|
0.35
|
126.5
|
August 18, 2025
|
August 28, 2025
|
|
|
Q3 2025
|
0.35
|
126.1
|
November 10, 2025
|
November 19, 2025
|
|
|
Total
|
$
1.05
|
$
378.9
|
|||
|
Common Stock Dividends - Dividend Year 2024
|
|||||
|
Quarter
|
Dividend per
Common Share
|
Dividend to
Common
Stockholders
|
Record Date
|
Payment Date
|
|
|
(Dollars in millions, except per share data)
|
|||||
|
Q1 2024
|
$
0.35
|
$
125.6
|
May 14, 2024
|
May 21, 2024
|
|
|
Q2 2024
|
0.35
|
125.5
|
August 16, 2024
|
August 26, 2024
|
|
|
Q3 2024
|
0.35
|
125.2
|
November 18, 2024
|
November 25, 2024
|
|
|
Q4 2024
|
0.35
|
126.4
|
February 21, 2025
|
February 28, 2025
|
|
|
Total
|
$
1.40
|
$
502.7
|
|||
|
|
Nine Months Ended September 30,
|
||
|
|
2025
|
2024
|
|
|
|
(Dollars in millions)
|
||
|
Statements of Cash Flows Data
|
|||
|
Net cash used in operating activities
|
$
(2,080.4)
|
$
(406.7)
|
|
|
Net cash used in investing activities
|
(57.4)
|
(50.9)
|
|
|
Net cash provided by financing activities
|
3,015.4
|
370.7
|
|
|
Effect of foreign exchange rate changes
|
82.3
|
23.7
|
|
|
Net change in cash, cash equivalents and restricted cash
|
$
959.9
|
$
(63.2)
|
|
|
Oct. 1, 2025 to
Dec. 31, 2025
|
2026-2027
|
2028-2029
|
Thereafter
|
Total
|
|||||
|
|
(Dollars in millions)
|
||||||||
|
Debt obligations
(1)
|
$
8.2
|
$
115.4
|
$
522.1
|
$
2,368.6
|
$
3,014.3
|
||||
|
Interest payable
(2)
|
37.4
|
291.0
|
277.7
|
1,780.1
|
2,386.2
|
||||
|
Other consideration
(3)
|
3.7
|
36.0
|
27.6
|
—
|
67.3
|
||||
|
Operating lease obligations
(4)
|
18.4
|
149.6
|
146.6
|
255.6
|
570.2
|
||||
|
Capital commitments to Carlyle funds
(5)
|
4,062.1
|
—
|
—
|
—
|
4,062.1
|
||||
|
Tax receivable agreement payments
(6)
|
—
|
11.0
|
12.6
|
48.0
|
71.6
|
||||
|
Loans payable of Consolidated Funds
(7)
|
100.3
|
796.2
|
797.2
|
10,904.6
|
12,598.3
|
||||
|
Unfunded commitments of the CLOs
(8)
|
13.7
|
—
|
—
|
—
|
13.7
|
||||
|
Consolidated contractual obligations
|
4,243.8
|
1,399.2
|
1,783.8
|
15,356.9
|
22,783.7
|
||||
|
Loans payable of Consolidated Funds
(7)
|
(100.3)
|
(796.2)
|
(797.2)
|
(10,904.6)
|
(12,598.3)
|
||||
|
Capital commitments to Carlyle funds
(5)
|
(3,388.1)
|
—
|
—
|
—
|
(3,388.1)
|
||||
|
Unfunded commitments of the CLOs
(8)
|
(13.7)
|
—
|
—
|
—
|
(13.7)
|
||||
|
Carlyle Operating Entities contractual obligations
|
$
741.7
|
$
603.0
|
$
986.6
|
$
4,452.3
|
$
6,783.6
|
||||
|
Nine Months Ended
September 30,
|
|
|
2025
|
|
|
Balance, beginning of period
|
357,183,632
|
|
Shares issued
|
7,189,022
|
|
Shares repurchased/retired
|
(4,236,146)
|
|
Balance, end of period
|
360,136,508
|
|
Period
|
(a) Total number of
shares
purchased
|
(b) Average
price paid per
share
|
(c) Total number of
shares purchased as
part of publicly
announced plans or
programs
|
(d) Maximum number (or
approximate dollar value)
of shares that may yet be
purchased under the plans
or programs (3)
|
|
(Dollars in millions, except share and per share data)
|
||||
|
July 1, 2025 to July 31, 2025 (1)
|
—
|
$
—
|
—
|
$
879.3
|
|
August 1, 2025 to August 31, 2025 (1)(2)
|
1,101,099
|
$
63.69
|
1,101,099
|
$
809.2
|
|
September 1, 2025 to September 30, 2025
(1)(2)
|
467,300
|
$
63.93
|
467,300
|
$
779.3
|
|
Total
|
1,568,399
|
1,568,399
|
||
|
Exhibit No.
|
Description
|
|
3.1
|
|
|
3.2
|
|
|
4.1
|
|
|
4.2
|
|
|
4.3
|
|
|
10.1*
|
|
|
22*
|
|
|
31.1*
|
|
|
31.2*
|
|
|
32.1**
|
|
|
32.2**
|
|
|
101.INS
|
Inline XBRL Instance Document - the Instance Document does not appear in the Interactive Data File because its
XBRL tags are embedded within the Inline XBRL document.
|
|
101.SCH
|
Inline XBRL Taxonomy Extension Schema Document.
|
|
101.CAL
|
Inline XBRL Taxonomy Extension Calculation Linkbase Document.
|
|
101.DEF
|
Inline XBRL Taxonomy Extension Definition Linkbase Document.
|
|
101.LAB
|
Inline XBRL Taxonomy Extension Labels Linkbase Document.
|
|
101.PRE
|
Inline XBRL Taxonomy Extension Presentation Linkbase Document.
|
|
104
|
The cover page from The Carlyle Group Inc.’s Quarterly Report on Form 10-Q for the quarter ended
September 30, 2025
, formatted in Inline XBRL (included within the Exhibit 101 attachments).
|
|
*
|
Filed herewith.
|
|
**
|
Furnished herewith.
|
|
|
The Carlyle Group Inc.
|
|||
|
Date: November 7, 2025
|
|
By:
|
|
/s/ John C. Redett
|
|
|
Name:
|
|
John C. Redett
|
|
|
|
Title:
|
|
Chief Financial Officer
|
|
|
|
|
(Principal Financial Officer and
Authorized Officer)
|
||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|